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  The arcuate nucleus of the hypothalamus serves as a critical node for regulation of 
mammalian energy balance with the ability to sense the status of many organ systems and exert 
control over effector arms that potently regulate feeding behavior and energy expenditure. The 
goals of this dissertation were 1) To identify hypothalamic adaptations driven by exercise 
induced energy expenditure related to conferral of whole body health improvement and 2) To 
investigate synaptic adaptations that occur in AgRP/NPY neurons of the hypothalamus in 
response to hunger.  
 Chronic ad libitum feeding on high fat diet induces energy surplus, while exercise 
increases energy expenditure. To investigate the role of exercise to offset the effects of energy 
surplus, 8 week-old male C57BL/6J mice were provided with 1) normal chow, 2) with western 
style high fat diet, or 3) with high fat diet and voluntary running wheel exercise training for 12 
weeks. Exercise training decreased high fat diet induced adiposity by increased energy 
expenditure, without impacting caloric consumption. Along with changes to body composition, 
mice that exercised exhibited improved glucose clearance and skeletal muscle insulin sensitivity 
paired with reduced liver lipid accumulation and less adipose tissue expansion than their 
sedentary counterparts. These peripheral adaptations occur in concordance with improved 
hypothalamic leptin sensitivity and reduced pro-opiomelanocortin neuronal apoptosis.  
 
 
 On the other hand, short term energy deficit induced by an overnight fast elicits 
activation of hypothalamic AgRP/NPY neurons to drive feeding behavior. Many hormonal and 
neuronal inputs contribute to the activation of AgRP/NPY neurons, including release of the 
excitatory neurotransmitter glutamate. Therefore, we investigated the influence of fasting on 
synaptic integration of glutamate by metabotropic glutamate receptor 1 (mGluR1) on AgRP/NPY 
neurons. Fasting enhances function of mGluR1 to increase excitability of AgRP/NPY neurons, 
while loss of mGluR1 function reduces AgRP/NPY neuronal firing and reduces feeding 
behavior.  
 Perturbation of hypothalamic action by intake/expenditure components of energy balance 
provides insight into mechanisms that can be leveraged for many disease states, including 
obesity and diabetes. Taken together, these discoveries elucidate adaptations of the arcuate 
nucleus hypothalamus to support its role as a critical node involved in maintenance of energy 
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 Obesity and diabetes arise from chronic energy surplus, resulting in adaptation and 
dysfunction across many organ systems. While primary adaptations may provide short term 
benefits, energy surplus increases chronic load across organ systems. Obesity and diabetes are 
risk factors and increase severity of costly diseases such as cardiovascular disease, 
hypertension142, liver disease125, acute pancreatitis108, infection susceptibility121, cancer35, kidney 
disease161, osteoarthritis139, dementia and Alzheimer’s76, depression and anxiety100. 
Obesity and Diabetes: Dysfunction across Organ Systems 
 The consequences of chronic energy surplus distribute across many organ systems. While 
the influence of energy surplus can be partially offset by distribution of load across many organ 
systems in the short term, this also means that the damage over time is wide spread. 
Deterioration of function by the liver, pancreas, vasculature, heart, adipose, skeletal muscle and 
kidenys all contribute to the progression of obesity and diabetes. 
 Chronic energy surplus places substantial burden on the liver. Surplus free fatty acid 
increases hepatic TG synthesis and atherogenic very low density lipoproteins6. In addition, 
accumulation of fatty acyl CoA156 indirectly inhibits insulin receptor substrate 1(IRS-1) – 
compounding insulin resistance and exacerbation of gluconeogenesis. While the liver typically 
acts as a short term reservoir to release energy as glucose during fasting, in the obese state the 
liver senses energy deficit despite energy surplus. This results in increased glucose output even 
when glucose levels are not low, which further elevates blood glucose levels.  
 For the pancreas under chronic hyperglycemia, apoptosis of β cells reduces the pool of 




expression for insulin via a reduction in the promoter region for the transcription factors PDX-1 
and MafA. Together, the “double jeopardy” that occurs in the pancreas drives overt diabetes144. 
Further, while small amounts of circulating lipids can enhance glucose stimulated insulin 
secretion, accumulation of lipids in islets impairs insulin secretion16. Obesity and diabetes thus 
combine to influence pancreatic maladaptation by induction of hyperinsulinemia and a 
subsequent loss of insulin secretion. 
 The vascular system provides a route of transit for energy substrates and hormones. In the 
case of obesity, high levels of circulating atherogenic very low density lipoproteins (VLDL) 
cause occlusion to the vasculature. Dynamic endothelial function gives way to arterial stiffness 
in the case of obesity, evidenced by decreased arterial compliance even in obese children171. 
Intracellular signal mediators also play a role in obesity and type 2 diabetes’ contribution to 
vascular dysfunction. Chronic elevation of activity by protein kinase Akt and mammalian target 
of rapamycin (mTOR) induce vascular senescence and potentiate ischemic injury180. Further, 
lowered adiponectin leads vascular inflammation by reduced anti-inflammatory input. Obesity 
wreaks havoc on the cardiovascular system marked by systolic and diastolic dysfunction with 
increased risk of ventricular dysrhythmia90. Specifically within the heart a number of 
adaptations arise in response to obesity. Marked left ventricular hypertrophy and increased heart 
rate temporarily provide the bloodflow required to maintain function89, but obesity and insulin 
resistance predict coronary heart disease.   
 Skeletal muscle consumes the majority of glucose relative to other organ systems, and 
has the capacity to rapidly remove large amounts of glucose from the bloodstream. For skeletal 




of insulin induced Glut4 translocation significantly impairs glucose uptake – resulting in muscle 
fatigue and compounding the energy surplus phenotype with physical inactivity6. 
 Adipose undergoes prominent expansion from chronic energy surplus and obesity is 
marked by hypertrophy of white adipose cells. Intra-abdominal fat correlates highly with insulin 
resistance18. However, the role of adipose in the development of metabolic disease goes well 
beyond its role as a storage depot for lipids. The inflammation response to adipose is marked by 
macrophage accumulation inducible Nitric Oxide Synthase, Interleukin-6 (IL-6), and Tumor 
Necrosis Factor Alpha (TNF-α) expression182. Leptin levels correlate directly and positively with 
adiposity76 to signal high levels of energy storage. Paradoxically, despite increased adiposity, 
obesity results in decreased adiponectin secretion5. 
 Kidney disease develops in nearly a third of diabetic patients and is marked by 
enlargement of the kidneys and significantly elevated glomular filtration184, often associated with 
macroalbuminuria. Generation of reactive oxygen species under hyperglycemic conditions 
contributes to pathogenesis47. Individuals who have co-morbid kidney disease and obesity have a 
significantly higher mortality rate than those with diabetes alone1.  
Altered Profile of Circulating Factors with Obesity and Diabetes 
 In order for organisms to house cooperative organ systems, a mode of communication 
between systems had to evolve. The most fundamental form of organ system communication 
occurs through circulation of factors via liquid transport such as blood or cerebrospinal fluid. 
This allows for transportation of energy substrates, hormones, and inflammatory signals. In the 





 The early stages of type 2 diabetes are marked by skeletal muscle insulin resistance, 
followed by hyperinsulinemia in response to poor glucose clearance. Over time, β-cell failure 
arises as these cells are unable to keep up with whole body demand36. Mild symptoms such as 
blurry vision, a headache or stomach ache can set in. The hyperglycemia underlying these 
symptoms can be resolved by insulin injection at early stages in diabetes10. If untreated, severe 
cases of hyperglycemia cause ketoacidosis and can lead to a deadly situation over the course of 
hours.  
 Leptin is a satiety signal in the body that communicates peripheral energy surplus. 
Increased circulating leptin levels occurs with the expansion of adiposity. As a signal, leptin 
notifies target cells of energy surplus. While diabetes does not directly influence leptin levels105, 
obese patients have significantly higher free (bioactive) leptin levels than lean counterparts157. 
However, given that chronic high levels of leptin can result in leptin insensitivity, approaches to 
reduce circulating leptin levels may have therapeutic value25.  
 As obesity and diabetes progress, the stimulation of Glucagon like Peptide-1 (GLP-1) and 
Peptide YY (PYY) by meal ingestion becomes blunted105, 116. While an empty stomach typically 
signal the release of ghrelin, food intake fails to suppress ghrelin secretion in obese individuals42.  
However, in diabetic individuals post-prandial suppression of ghrelin remains intact151. 
 Obesity comes with a profound disturbance to stress hormone profile. Obese patients 
have higher levels of circulating norepinephrine72. In addition, poorer control of type 2 diabetes 
correlates with higher levels of norepinephrine157. Further, cortisol regulation is altered in 
obesity. Opposing effects maintain cortisol at similar levels between obese and lean subjects. In 




control of the hypothalamic-pituitary-adrenal axis4. However, increased clearance is offset in 
women by reduced 5β-reductase activity or cortisol regeneration in men. In men, regeneration of 
cortisol occurs primarily in the liver to drive transcription of gluconeogenic enzymes while 
blockade of cortisol regeneration leads to hypoglycemia and improved insulin sensitivity.  
 Hormones work to transmit information across organs through circulation. In the cases of 
obesity and type 2 diabetes, chronic energy surplus distributes load across organs. As organ 
systems directly adapt to chronic energy surplus they also have to adapt to each other. Given the 
specificity of hormones to act only on individualized receptors via specific molecular 
mechanisms, the endocrine system is insufficient to coordinate the broad range of adaptations 
across organ systems. 
Hypothalamic Integration of Energy Availability and Organ System Inputs 
 Central control of the periphery is a hallmark of the success of the metazoans which 
permitted the integration of organ system level inputs and command of coordinated responses23. 
The hypothalamus serves as the key integration center for inputs related to energy balance. 
While the blood-brain barrier (BBB) provides a formidable blockade to bloodborne signals for 
most of the brain, the ventral portion of the hypothalamus has unique access to circulating 
factors. The median eminence is open to portal vessels145 and can control transport of molecules 
across the BBB into cerebrospinal fluid8. The arcuate nucleus (ARC) is highly exposed to 
cerebrospinal fluid – further evidencing an anatomical basis for the role as receiver of peripheral 
signals. 
 Action of energy surplus signals within the hypothalamus is critical for maintaining 




causes hyperphagia and insulin resistance129. Chronic high fat diet results in apoptosis of 
hypothalamic neurons by activation of inflammatory pathways which results in resistance to 
insulin111. Direct injection of GLP1 to the ARC, but not other hypothalamic regions, results in 
reduced hepatic glucose production147. Peptide YY directly blocks fasting induced activation of 
the ARC143. Leptin acts directly on POMCARC neurons but also indirectly reduces inhibitory tone 
by acting on GABAergic neurons178. Deletion of leptin receptor results in an obese phenotype 
comparable to leptin deficient ob/ob mice31. 
 Signals of energy deficit are similarly reliant on direct hypothalamic action. Mice lacking 
the growth hormone secretagogue receptor exhibit blocked arcuate nucleus activation and 
subsequent food intake that typically occurs200. This effect is striking and consistent with the 
effects of diet-induced obesity to cause ghrelin resistance of arcuate neurons20.   
 Relay of autonomic afferents exerts substantial influence over hypothalamic function. 
The locus coeruleus contains many neurons with norepinephrine (NE) precursor tyrosine 
hydroxylase (TH) that influence post-synaptic activity of the paraventricular hypothalamic 
nucleus by excitatory action. These neurons typically confer information about acute stress but 
also potentially function in a chronic fashion198 and are primarily directed at vasopressin 
expressing neurons within the magnocellular division of the PVH166.  
Nutrient/Hormone Responses of Neuronal Populations 
 The ARC is comprised of heterogeneous populations of neurons that co-respond to 
nutrient and endocrine signals related to energy balance. Classic models of arcuate control of 
energy balance pit molecularly defined POMC neurons and AgRP/NPY neurons as yin and 




 At the simplest level of sensing of energy balance, neurons within the ARC respond 
directly to glucose, lipid, and protein nutrients in the cerebrospinal fluid. A decrease in glucose 
levels can directly stimulate activation of a portion of Agouti-Related Peptide (AgRP) and 
Neuropeptide Y (NPY) neurons known as AgRP/NPY118, while an increase in glucose levels can 
directly stimulate activation of pro-opiomelanocortin (POMC) neurons32. 
 While neurons primarily use glucose for fuel, they also can oxidize lipids and serve as 
sensors of lipid levels. Reduction of carnitine palmitoyl transferase IA (CPT1A) activity by 
pharmacological inhibition or genetic knockdown of CPT1A in the medialbasal hypothalamus 
results in decreased food intake and glucose production. Disinhibited lipid flux prevents the 
accumulation of LCFA-CoA’s, which serve as an input to lipid sensing at the onset of nutrient 
surplus. Inhibiting CPT1A causes accumulation of long chain fatty acid CoA’s (LCFA-CoA) in 
the medialbasal hypothalamus and subsequently restores lipid sensing137. Well after the onset of 
impaired lipid sensing, at high levels of circulating fatty acids for multiple weeks, the 
accumulation of LCFA-CoA’s contributes to ARC insulin insensitivity and inflammation that 
impair hypothalamic control of energy balance138. 
 Leptin activates POMC neurons37 and simultaneously hyperpolarizes AgRP/NPY 
neurons11. The acute effects of leptin59 to depolarize POMC neurons depend upon 
phosphoinositide-3-kinase (PI3K) signaling and reduced input resistance. Conversely, insulin 
hyperpolarizes POMC and AgRP neurons via PI3K activation of tolbutamide sensitive potassium 
channels. Interestingly, the POMC neurons that respond to leptin and insulin are likely 
independent populations183. 




ARC. Instead, multiple hormones can work in opposition or cooperatively on ARC neurons to 
relay information. For example, adiponectin and leptin synergistically activate POMC neurons 
while adiponectin inhibits AgRP/NPY neurons. The effect of adiponectin on POMC neurons is 
also dependent upon glucose levels whereby adiponectin with high glucose has inhibitory action, 
while in low glucose it has excitatory action165. This partially explains why chronic elevation of 
glucose levels suppresses satiety and expenditure as in the cases of diabetes and obesity. On the 
other hand, Peptide YY143 and insulin165 block ghrelin activation of neurons in the ARC. This 
demonstrates that hormones can transmit information about energy status to their target in 
synergy or opposition. The unique nature of the neuron allows it to integrate information from 
many sources and produce an output that is consistent with demand across the body.  
HypothalamicARC Output Controls the Periphery 
 HypothalamicARC neurons have effector arms199 that regulate circuit dynamics broadly 
across the central nervous system (Figure 1.1B)  via direct projections to more than twenty brain 
regions181 comprised of many cellular subpopulations Together, these circuits form networks 
capable of dynamic regulation of energy balance across organ systems.  
 The ARC exerts profound influence over energy intake. Chemogenetic84 and 
optogenetic164 activation of AgRP/NPY neurons results in voracious feeding behavior. While the 
hypothalamus only contains a few thousand AgRP/NPY neurons, activation of just 100 of these 
neurons is sufficient to detect a measurable change in feeding behavior. Ablation of AgRP/NPY 
neurons in adult mice results in starvation, while ablation in neonates has minimal effects on 
feeding101.  Conversely, POMCARC neuron activation reduces chronic but not acute feeding 




 The ARC also controls energy expenditure. Ablation of POMC neurons results in 
reduced energy expenditure and locomotor behavior193. Likewise, genetic deletion of 
downstream target Melanocortin 4 Receptor (MC4R) results in reduced energy expenditure and 
obesity, while re-expression results in normalization of body mass9. Conversely, reduction in 
hypothalamic AgRP results in significantly increased heat production and VO2103. Consistent 
with this finding, central administration of AgRP reduces energy expenditure and bodyweight. 
Agonism of the NPY target Y5 receptor results in significantly reduced energy expenditure 
associated with decreased brown adipose tissue thermogenesis65. Chronic central administration 
of AgRP results in reduced energy expenditure159. Consistently, deletion of GABAergic 
transmission from AgRP neurons results in significantly increased energy expenditure170.  
 Ablation of POMCARC neurons results in glucose intolerance and increased circulating 
cholesterol levels (HDL-C and LDL-C). Insulin receptor activation in POMCARC neurons results 
in significantly increased hepatic glucose production, while insulin receptor activation in 
AgRP/NPY neurons results in suppressed hepatic glucose production98. Some reports show that 
insulin depolarizes a subset of AgRP/NPY neurons2, 30. However, in a study that recorded from a 
much larger sample of AgRP/NPY neurons and biotin-marked the selected neurons, zero were 
found to be depolarized by insulin68. 
 The canonical hypothalamic-pituitary-adrenal (HPA) axis serves as the controller of 
stress hormone levels throughout the body. Pituitary inputs originating from the parvocellular 
region of the PVH secrete corticotropin-releasing factor onto corticotropes160. This induces the 
pituitary release of adrenocorticotropic hormone into circulation and subsequently increases 




in the mangocellular region of the PVH induces phospholipase C mediated signaling in the 
pituitary that amplifies the effects of ACTH. 
 Central signaling in the canonical hypothalamic-pituitary-thyroid (HPT) axis originates 
with hypothalamic function. TRH neurons receive substantial innervation from arcuate POMC 
and AgRP/NPY neurons. Activity and production of pro-Thyrotropin Releasing Hormone in 
thyrotropin-releasing hormone (TRH) expressing neurons of the PVH is suppressed by AgRP 
and NPY, while it is activated by alpha-melanocyte stimulating hormone (α-MSH). During 
fasting, leptin levels typically drop and TRH activity becomes blunted93 by enhanced antagonism 
of the function of α-MSH. Exogenous leptin administration can prevent fasting suppression of 
pro-TRH mRNA. Pharmacological ablation of the arcuate nucleus of the hypothalamus results in 
profound disruption to the HPT axis92, which is consistent with reduced TRH administration by 
intracerebroventricular administration of AgRP and NPY46.  
 Genetic deletion of AgRP and NPY results in complete inhibition of feeding behavior 
induced by ghrelin injection, suggesting that output by AgRP/NPY neurons is the key mediator 
in ghrelin’s effect on hunger28. Interestingly, ghrelin can act directly on neurons in the ventral 
tegmental area158, 74, 123 and can increase dopamine in the nucleus accumbens69. Taken together, 
these studies demonstrate that reward centers play an augmentative role for AgRP/NPY output.   
 Autonomic regulatory centers are under the influence of alpha-MSH target melanocortin 
receptors. POMC neurons are localized to both the ARC and the nucleus tractus solitarii (NTS). 
POMCARC neurons project directly to autonomic centers such as the NTS, area postrema (AP), 
dorsal motor nucleus (DMNX), and around the central canal197.  Interestingly, very few direct 




level21, but projections to common downstream sites of the NTS suggests that they influence 
integration of satiety signals relayed by viscerosensory afferent nerves. Activation of the DMV 
and NTS results in enhanced parasympathetic induction of insulin secretion, while 
subdiaphragmatic vagotomy results in loss of pacemaker input to the pancreas for pulsatile 
secretion of insulin22.   
 AgRP/NPY neuronal GABAergic transmission onto the parabrachial nucleus supports 
conferral of taste information and feeding behavior. Loss of this transmission results in 
starvation186 which interestingly occurs independent of the melanocortin system185. Loss of 
AgRP and NPY gene expression results in mice that are indistinguishable from wild-type mice 
by measurement of bodyweight or leptin responsiveness, further suggesting that the function of 
AgRP/NPY neurons goes beyond their ability to release those peptides136.  
 Intracerebroventricular orexin, which translates to the greek word appetite, significantly 
increases food intake152. Orexin expressing neurons of the lateral hypothalamus project to the 
locus coeruleus to increase arousal and locomotor activity55. Lateral hypothalamic orexin 
neurons receive terminal appositions from AgRP/NPY neurons as well as α-MSH 
immunoreactive fibers41, suggesting that arcuate neurons contribute to relay circuitry connecting 
the central nervous system to whole body energy demand.  
 Arcuate Rat Insulin Promotor (RIP) neuron activation results in significantly increased 
whole body energy expenditure via brown adipose tissue thermogenesis, while loss of inhibitory 
transmission from these neurons by genetic deletion of vesicular GABA transporter (vGAT) 
results in obesity by impaired thermogenesis80.  




puberty and fertility. Kisspeptin neurons provide pulsatile excitatory input to gonadotropin-
releasing hormone 1 (GnRH) neurons124 by release of synaptic glutamate and neurokinin B. 
GnRH neurons control pulsatile secretion of luteinizing hormone124. Interestingly, Kisspeptin 
neurons link nutrition state and fertility by direct release of glutamate onto both AgRP/NPY 
neurons and POMC neurons141. The function of this release is mediated by metabotropic 
glutamate receptors whereby AgRP/NPY neurons are inhibited by mGlur2/3 and POMC neurons 
are excited by mGluR1127. 
The Effect of Energy Surplus on the Nervous System 
 In the obese state, the arcuate nucleus of the hypothalamus and peripheral organ systems 
become disjointed. Diet-induced obesity in rats exhibit increased AgRP mRNA94 or at least a 
greater decrease of POMC than AgRP mRNA43. Obesity results in impaired glucose sensing by 
POMCARC neurons32. Knockout of energy sensor AMP-activated protein kinase (AMPK) in 
AgRP and POMC neurons impairs typical neuronal response to glucose levels and results in a 
lean phenotype or an obese phenotype, respectively30. Diminished function of glucose sensors 
results in dysregulation of arcuate effector arms and compounds the progression of obesity by 
promoting energy intake and impairing expenditure. 
 Increases in blood lipid levels corresponds with increased lipid level measurements taken 
from the third ventricle by catheterization. In food restricted mice compared to mice fed ad 
libitum, central administration of oleic acid results in decreased AgRP and NPY mRNA114.  
While high circulating lipid levels typically induce a negative feedback loop to reduce food 
intake, hypothalamic lipid sensing becomes rapidly impaired after feeding on a high fat diet. 




paired with increased CPT1A activity prevents intracellular accumulation of LCFA-CoA’s in 
response to high circulating lipids. Consistently, inhibition of hypothalamic CPT1A or 
hypothalamic beta-oxidation restores lipid sensing via accumulation of LCFA-CoAs, resulting in 
decreased food intake and glucose production137. Taken together these studies demonstrate that 
hypothalamic lipid detection is a critical component of the hypothalamic role as sensor and 
regulator of whole body energy balance. 
 Diet-induced obesity causes leptin resistance44 via reduced hypothalamic access and 
impaired intracellular signaling40. Reduced access is attributable to impaired ERK-gated 
signaling in tanycytes that transport leptin across the blood-brain barrier8 resulting in altered 
blood to CSF leptin ratio27. Consistently, in the early phase of obesity, peripheral injection of 
leptin can activate ARC Signal Transducer and Activator of Transcription 3 (STAT3) signaling, 
but eventually peripheral injection becomes ineffective to activate ARC STAT3.  In mice lacking 
leptin receptors (db/db), STAT signaling is markedly impaired50. Modeling high leptin levels 
observed in obesity by chronic administration of leptin results in reduced leptin receptor mRNA 
and protein levels107. However, even with elevated levels of leptin observed with obesity, poor 
site of action accessibility paradoxically sensitizes the ARC to leptin such that fasting induced 
activation of AgRP/NPY neurons and phosphorylation of STAT3 is substantially blunted in diet-
induced obese (DIO) mice but not leptin deficient ob/ob mice12. In healthy mice, 
electrophysiological recordings in artificial cerebrospinal fluid (aCSF) reveal that fasting 
enhances firing rate and reduces resting membrane potential compared to fed status167, 99. In ex 
vivo recordings conducted outside of the physiological milieu, AgRP/NPY neuronal firing rate of 




rate enhancement is larger for fed mice compared with fasted11. Interestingly, loss of bodyweight 
restores leptin signaling in POMCARC and AgRP/NPY neurons43. Taken together, these studies 
demonstrate that the ARC sensing of energy balance by leptin is markedly impaired in obesity 
and type 2 diabetes which disrupts coordination of hypothalamic effector arms. 
 Obesity blunts the action of insulin to suppress NPY mRNA150 and induce K-ATP 
channel activation in neurons that become hyperpolarized by decreases in glucose160, such as 
POMCARC neurons66. Central administration of insulin via an intracerebroventricular cannula 
results in less PI3K activation in long-term high fat fed rats compared to low fat fed rats, which 
is attributable to inflammation resulting from increased palmitoyl and stearoyl-CoA’s that is 
blocked via IKKβ inhibitor138. Abundance of circulating palmitic acid, but not oleic acid, results 
in increased membrane Protein Kinase Cϴ (PKCϴ) and blunts insulin-induced phosphorylation 
of AKT. Genetic deletion of PKCϴ prevented impairment of insulin signaling induced by 
administration of palmitic acid13. Modeling insulin resistance on AgRP/NPY neurons by deletion 
of insulin receptor results in a loss of suppression of hepatic glucose production – which would 
further compound the high glucose levels and progression of diabetes even without changes in 
food intake or bodyweight81. In summary, hypothalamic insulin action is important for 
maintaining whole body energy balance despite not being as direct in terms of substrate 
utilization as peripheral tissues. 
 DIO models exhibit ghrelin resistance marked by blunted ghrelin-induced activation of 
AgRP/NPY neurons, diminished ghrelin induced enhancement of AgRP/NPY transcriptional 
activation, and suppressed ghrelin induced feeding behavior. However, central administration of 




Ghrelin induced activation of feeding behavior is also blunted in the pre-obese and obese agouti 
mouse model, while these mice exhibit enhanced melanocortin independent sensitivity to the 
anorectic effects of Peptide YY107. 
 Genetically obese mice (C57BL/6Job/ob) have significantly reduced brain weight, 
cortical volumes. Additionally, these mice exhibit decreased cross-sectional area of the 
ventromedial hypothalamus and dorsal motor nucleus of the vagus14. The autonomic nervous 
system of an obese individual is marked by increased sympathetic activity but decreased 
parasympathetic activity at the heart71. Many dysfunctional cardiovascular adaptations driven by 
obesity are reversed by weight loss via reduced sympathetic activity and cardiac hypertrophy89. 
Consistent with these findings, heart rate variability analysis reveals that obese patients who lose 
weight exhibit improved autonomic balance90. 
 Diet induced obesity results in a chronic low grade inflammatory response in the central 
nervous system that is attributable to increased recruitment of macrophages originating from 
bone marrow24. Disruption of NF-κB and IKK/β results in protection from obesity, while their 
enhancement results in increased SOCS3 inhibition of leptin and insulin signaling195. 
Interestingly, cerebrospinal fluid borne IL-6 is negatively correlated with obesity and leptin 
levels163, suggesting an obesity induced deficiency in the production of IL-6 in the brain. Loss of 
bodyweight reverses IL-6 and IL-10 deficiencies in human cerebrospinal fluid175.  
Exercise as Medicine for the Central Nervous System 
 Exercise exerts profound effects on the function of an organism’s circulating hormones. 
Acute exercise increases circulating ghrelin levels3, acyl-ghrelin levels, and glucagon levels 104. 




aerobic exercise training lowers circulating insulin levels, reversing the hyperinsulinemia driven 
by hyperglycemia201. Chronic exercise training also decreases circulating leptin levels25. Exercise 
training decreases circulating and hypothalamic catecholamine levels in a manner highly 
correlated with decreased fat mass87. 
 Exercise also improves target-site function such as hypothalamic insulin sensitivity by 
inducing IRS2 expression133 and phosphorylation of AKT as well as leptin signaling through 
JAK2/STAT3133, 196. While high-fat diet results in hypothalamic insulin and leptin insensitivity 
partially by activation of IKKβ/NF-κB, exercise promotes hypothalamic IL-6 and IL-10 
inhibition of IKKβ/NF-κB. Alteration to pro-inflammatory signals that suppress IKKβ/NF-κB 
are necessary for exercise induced improvement in insulin/leptin function146. Consistent with the 
role of exercise to improve inflammatory mediated neuronal function, exercise reduces high fat 
diet induced microglial activation192.  
 One week of exercise ameliorates the elevation of hypothalamic NPY mRNA associated 
with diabetes progression in a streptozotocin rat model of type I diabetes153. Reduced NPY 
mRNA also occurs with three134 or eight weeks of voluntary wheel running in WT mice. 
Paradoxically, low NPY and AgRP gene expression typical of MC4R knockout mice becomes 
normalized by the same exercise program, but is offset by a decrease in orexin mRNA56 which 
shows functional enhancement of the melanocortin system coupled with maintenance of energy 
balance across multiple networks. Acute exercise increases levels of hypothalamic POMC 
mRNA immediately after exercise. POMC mRNA is still elevated for at least three hours after 
cessation of activity70. In MC4R knockout mice, chronic exercise offsets the massive increases in 




– suggesting healthy energy balance largely relies on normalized balance between AgRP/NPY 
and POMC neuronal output relative to hormonal inputs. 
 During exercise, glucose utilization and glucose production become markedly increased, 
while blood glucose levels remain relatively close to baseline179. Exercise normalizes blood lipid 
profile by decreasing LDL, cholesterol, and triglyceride levels while also increasing HDL levels 
199, which may help restore hypothalamic lipid sensing in impaired conditions. While acute 
exercise increases skeletal muscle energy sensor AMPK activity, one hour of acute exercise does 
not influence AMPK activity or phosphorylation of AMPK target Acetyl CoA Carboxylase in 
the hypothalamus3. 
 An acute bout of aerobic54 or resistance189 exercise training transiently increases brain 
derived neurotropic factor levels (BDNF). While much attention has been paid to the benefits of 
BDNF for cognitive performance 177, the role of BDNF to influence metabolic diseases also 
indicates potential benefits. Intracerebroventricular administration of brain derived neurotropic 
factor (BDNF) increases pancreatic insulin content and brown adipose tissue uncoupling protein 
mRNA, resulting in decreased blood glucose levels128. Interestingly, less than 20% of 
AgRP/NPY or POMC neuron cell bodies are immunoreactive for the BDNF receptor Tyrosine 
Receptor Kinase (TrkB). The population of BDNF expressing arcuate neurons is independent of 
leptin receptor (LepR) expressing neurons. However, leptin indirectly activates BDNF 
expressing VMH neurons to promote leptin sensitivity and satiety through the arcuate nucleus. 
Consistently, deletion of BDNF impairs leptin arcuate sensitivity, reduces POMC projections to 




























Figure 1.1:  Inputs to and outputs of the arcuate nucleus integrate whole body energy 
balance. (A)  Diagram of circulating and neuronal inputs to the arcuate nucleus. Glucagon and 
ghrelin increase in response to acute exercise200 and have a depolarizing effect on AgRP/NPY 
neurons68. On the other hand, acute exercise decreases insulin levels200 and chronic exercise 
decreases leptin levels25. Subsets of neurons within the PVH and DMH release excitatory 
glutamate onto arcuate AgRP/NPY neurons85, while subsets of VMH neurons in release glutamate 
onto POMC neurons. (B)Output from POMC neurons increase satiety by output onto subsets of 
neurons in the PVH and VMH. Output from AgRP/NPY neurons antagonize satiety at the PVH, 
VTA, and PBN. The NTS relays physiological satiety from the periphery to the PBN, while 




Statement of the Problem 
 Diseases of chronic energy surplus such as obesity and diabetes impact over 80 million 
Americans. As diseases driven by energy surplus trend upwards across the population, so do the 
burden of direct and indirect medical costs. Diseases of energy surplus present additional 
complexity for treatment of costly co-morbid diseases such as heart disease, chronic obstructive 
pulmonary disease, Alzheimer’s disease, arthritis and many more. Therefore, a focus on the 
underpinnings of energy surplus may yield benefits across many diseases. 
 Mammals have enormous energy storage capacity that evolved under the selective 
pressure of low nutrient availability. However, rampant chronic energy surplus has emerged 
from a sedentary western society with highly available energy dense foods. While it is clear that 
energy surplus has negative health consequences, the mechanistic influence of normalized 
energy balance on positive health benefits via CNS control is incompletely explored. In a healthy 
individual, competing neuronal circuits influence satiety and hunger. Chronic energy surplus 
compounds detrimental effects by altering controllers of energy intake and expenditure towards 
thriftiness – starving in the midst of plenty.  This dissertation will address adaptations of the 
arcuate nucleus in response to energy surplus, and test two approaches towards improved energy 









Voluntary exercise improves hypothalamic and metabolic function in obese mice 
 
Abstract: 
  Diseases of energy surplus such as diabetes and obesity have enormous financial 
and quality of life cost. One of the best known approaches to combat energy surplus is with 
increased energy expenditure. Therefore, we set out to determine the effects of 12 weeks running 
wheel exercise paired with ad libitum access to western style high fat diet. Voluntary wheel 
running improved body composition by reduction in adiposity across many depots (P < .05) 
without altering caloric consumption (P > .05). In addition, whole body glucose tolerance and 
insulin sensitivity is improved (P < .05). While these adaptations have been previously well 
explored, we demonstrate that exercise offsets damage of high fat diet induced apoptosis in 
POMC neurons and prevents hypothalamic leptin insensitivity. These adaptations occur in 
concordance with improvement to peripheral organ systems such as reduced liver steatosis, 
improved white adipose tissue morphology, and improved skeletal muscle insulin sensitivity. 
Taken together, this study identifies hypothalamic adaptations that may underlie the long-term 
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 Obesity is reaching epidemic proportions in North America, affecting American society 
with increased morbidity and mortality as well as economic cost82. Obesity is usually associated 
with defects of energy intake and energy expenditure, which are tightly controlled by the CNS 
139. The CNS controls the important aspects of metabolism, particularly in the hypothalamus, 
where neurons directly respond to physiological changes such as hunger and satiety by secreted 
cytokines or hormones. Distinct nuclei within the hypothalamus such as arcuate (ARC), the 
paraventricular nucleus, the ventromedial hypothalamus (VMH), the dorsomedial hypothalamus 
(DMH), and the lateral hypothalamus share neuronal interconnections to maintain body 
homeostasis120. Although many neurons in the hypothalamus regulate metabolic functions, pro-
opiomelanocortin (POMC)- expressing neurons, located in the ARC area, are key regulators of 
energy metabolism. Genetic ablation of POMC neurons causes increased food intake and 
reduced energy expenditure, leading to characteristics of the obese phenotype such as increased 
body weight and adiposity53, 195. Conversely, activation of POMC neurons suppresses food 
intake, increases energy expenditure, and induces the characteristics of the lean phenotype, such 
as decreased body weight and adiposity193. This indicates that POMC neurons play critical roles 
in body weight regulation. HFD affects POMC neurons in the ARC evidenced by increased 
caspase 3 immunoreactivity and decreased POMC mRNA113. Because overnutrition and high-fat 
diet (HFD) induce hypothalamic dysfunction, this may compound consequences of obesity and 
insulin resistance often leading to type 2 diabetes 195. This suggests that POMC neurons are the 




 Exercise therapy is a proven and effective clinical intervention for treating obesity and 
related diseases, such as hyperlipidemia and type 2 diabetes mellitus173. Exercise stimulates 
glucose uptake by skeletal muscle from the blood51, decreases fat content from the adipose 
tissue73, and prevents fat accumulation in the liver67. Besides the effects of exercise on peripheral 
tissues, voluntary exercise also improves brain function. For instance, it enhances learning and 
memory ability associated with the hippocampal area of the brain to prevent cognitive 
dysfunction and Alzheimer’s172, 49, 45. 
 Historical studies have demonstrated the effects of exercise on the CNS that uses 
neurotransmitters and trophic factors involved in energy homeostasis, such as norepinephrine, γ-
amino butyric acid (GABA), serotonin (5-HT) 38, and brain-derived neurotrophic factor (BDNF) 
126. Furthermore, 40-day voluntary running wheel training significantly increases neuropeptide Y 
gene expression in Sprague–Dawley male rat ARC nucleus and DMH95. Recently, it has been 
reported that hypothalamic melanocortin receptor (MCR) expression has been associated with 
the exercise activity and nonexercise activity thermogenesis154. Although we have gained a better 
understanding that hypothalamic MCR signaling is highly regulated by the products of Pomc-
expressing neurons7, little is known about how exercise improves metabolic function via 
hypothalamic POMC-expressing neurons. In light of this gap, we sought to investigate the effects 
of voluntary exercise training on whole-body metabolic parameters and hypothalamic POMC 









 Eight-week-old C57BL6 male mice (n = 45) from Jackson lab (The Jackson Laboratory, 
Bar Harbor, ME, USA) were housed under controlled temperature and lighting conditions of 20–
22° and 12-h light:12-h darkness cycle. Once the experimental protocol was initiated, all mice 
were divided into three groups: chow group (control; n = 15 with regular diet containing 26% 
protein, 14% fat, and 60% carbohydrate), HFD group (n = 15, 16% protein, 58% fat, and 26% 
carbohydrate, Research Diets D12331; Research Diets, Inc., New Brunswick, NJ, USA), and 
HFD with exercise training (HFD + EX; n = 15, 16% protein, 58% fat, and 26% carbohydrate, 
Research Diets D12331) and voluntary running wheel (TSE PhenoMaster System, Bad 
Homburg, Germany) for 12 weeks. For the study of voluntary wheel running, age-matched 
animals in the HFD + EX group were placed in cages equipped with running wheels for mice 
(TSE PhenoMaster), whereas animals in the control group and HFD group were housed 
in cages without running wheels for 12 weeks. Each cage accommodated one mouse. All aspects 
of animal care and experimentation were conducted in accordance with the National Institutes of 
Health Guide for the Care and Use of Laboratory Animals (National Institutes of Health 
Publication no. 85-23, revised 1996) and approved by the Institutional Animal Care and Use 
Committees of East Carolina University (Greenville, NC, USA). 
Energy intake, energy expenditure, and body composition 
 Food intake was measured over a 5- to 7-day period, and the data were combined, 
averaged, and analyzed. Fresh pellets of food were provided every day to avoid temperature-




measured. Any residual bits of food in the bedding were included in measurements. Cumulative 
food intake data were obtained by adding all intake measurements during the study. Fat and lean 
body mass were assessed using Echo MRI (Echo Medical Systems, Houston, MA, USA). Energy 
expenditure was measured by assessing oxygen consumption and carbon dioxide production 
using an indirect calorimetry with Comprehensive Lab Animal Monitoring System (CLAMS; 
TSE PhenoMaster). Mice were acclimated in the CLAMS chambers for 72h before data 
collection, and had free access to food and water for the duration of the studies. 
Glucose tolerance test and insulin tolerance test 
 Two weeks before the last day of the experiment, an intraperitoneal glucose tolerance test 
(IPGTT) and an intraperitoneal insulin tolerance test (IPITT) were performed. After an overnight 
fast, IPGTT was performed by intraperitoneal injection of a 20% glucose solution (1g/kg). Blood 
samples were collected before and 15, 30, 60, 90, and 120 min after the injection. For IPITT, 
after a 4-h fast, an intraperitoneal injection of 1IU/kg human rapid insulin (Eli Lilly) was 
administered to the HFD-treated mice and 0.5U/kg human rapid insulin was administered to the 
chow diet-treated mice. Blood samples were collected before and 15, 30, 60, 90, and 120min 
after the injection. For the IPITT, the response of blood glucose levels was expressed as a 
percentage of the values before insulin injections. 
Morphological analysis of the liver and white adipose tissue 
 Serial sections (5µM thickness) were taken from the post-fixed liver and epididymal fat, 
followed by hematoxylin and eosin (H&E) staining as described previously63. The stained 
sections were photographed digitally using an optical microscope (Leica DM6000, Germany), 





 For fluorescence detection of POMC, coronal brain sections from 20-week-old mice in 
three groups were generated, and immunohistochemistry was performed as described previously 
62. Briefly, brain sections were incubated with antibody to POMC (Phoenix Pharmaceuticals, 
Burlingame, CA, USA) and further incubated with fluorescent-labeled secondary antibodies. 
POMC-positive neurons throughout the mediobasal hypothalamus were counted using ImageJ 
software (NIH, Bethesda, MD, USA). Three serial sections were analyzed in each mouse (n=3). 
Leptin-induced signal transducer and activator of transcription 3 phosphorylation 
 Mice were injected with leptin (A.F. Parlow National Hormone and Peptide Program, 
Torrance, CA, USA) intraperitoneally (3mg/kg) and killed 30 min later. The brain sections were 
evaluated for phosphorylatedSTAT3 (pSTAT3) in hypothalamus neurons as described previously 
155. Briefly, brain sections were incubated with an anti-pSTAT3 antibody (Cell Signaling), 
followed by an anti-fluoresces-conjugated rabbit antibody, pSTAT3 was then visualized under an 
optical microscope (Leica DM6000). All pSTAT3- immunoreactive ARC neurons were counted 
using ImageJ software (NIH). Cells within the median eminence were excluded from these 
analyses. Three serial sections were analyzed in each mouse (n = 3). 
Proliferative assay and tunnel assay 
 An endogenous proliferative marker Ki67 was used to determine the neuronal 
proliferation. Briefly, Ki67 antibody (Abcam) was used for a single immunolabeling study in 
brain sections among the three groups, followed by an anti-fluoresces-conjugated rabbit 
antibody. Ki67-positive cells throughout the mediobasal hypothalamus were counted using 




 A terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) 
assay was used to identify double-stranded DNA fragmentation. Briefly, coronal brain sections 
were washed in PBS, transferred to blocking solution for 2h, and then incubated in primary 
POMC antibody (Phoenix Pharmaceuticals) overnight. The next day, after washing, the sections 
were transferred to secondary antibody for 2h in light-deprived conditions. After being washed in 
PBS, samples were incubated at 4°C in permeability solution (PBS, 0.1% Triton-X, 0.1% sodium 
citrate) for 2min, and then incubated with TUNEL assay solution (In Situ Cell Death Detection 
Kit, Fluorescein, Sigma-Aldrich) for 1h at 37°. After being washed in PBS, all sections were 
mounted on slides with Vectashield antifade reagent. Negative and positive controls for the 
TUNEL assay were confirmed by staining the sections in the same manner without primary 
antibody (negative control) or pretreated with DNAse I (positive control). Positive cells were 
counted in the ARC from slides (n=3) of each group. 
Statistical Analysis 
 Data are expressed as mean ± standard error. Differences between groups were compared 
for statistical significance by ANOVA or two-tailed Student’s T-Test; P < .05 denoted 











Long-term voluntary exercise training lowers body weight gain and adiposity induced by HFD 
 To determine the effects of long-term voluntary running wheel exercise training on body 
weight regulation and adiposity, 45C57BL6 male mice were divided into three groups (control, 
HFD, and HFD+EX) for 12 weeks. Figures 1A and B show the average daily locomotion activity 
and running distance, respectively. Although HFD groups show lowered locomotion activity 
compared with the control group, the HFD+EX group shows significantly increased daily 
running distance, indicating increased total daily physical activity in the HFD+EX group. Next, 
we measured the body weight before and after the study, as shown in Figs. 1C and D; there was 
no difference in body weight among the three groups at the beginning of the study. However, the 
HFD group significantly increased body weight compared with the control group (41.1 ± 0.4 vs 
28.9 ± 1.1 g) after 12 weeks, and voluntary exercise training significantly lowered HFD-induced 
body weight gain (36.3 ± 1.7 vs 41.1 ± 0.4 g) at the end of the study. 
 Echo MRI data revealed that 12 weeks of HFD increased total fat mass significantly 
compared with the control group (Fig. 1E; 8.1 ± 1.9 vs 2.5 ± 0.4 g). Data also indicated that 12-
week of voluntary running wheel exercise training significantly reduced total fat mass (6.1 ± 1.7 
vs 8.1 ± 1.9 g) compared with the HFD group. There was no significant difference in total lean 
mass between the HFD groups (Fig. 1F).  
 By the end of the study, some regional fat pads were harvested and fat contents were 
weighed. Fat contents such as epididymal fat content (Fig. 1G; 0.61 ± 0.10 vs 0.75 ± 0.07 g), 




0.47 ± 0.09 vs 0.67 ± 0.12 g) were significantly decreased in the HFD +EX group compared with 
the HFD group.  
Voluntary exercise training reduces body weight via increased energy expenditure despite 
normal caloric intake in HFD fed mice 
 Change in body weight is controlled by energy intake and energy expenditure. To assess 
energy intake, food was weighed daily. Daily and cumulative caloric intake in all three groups 
was calculated at week 8 after the start date. At this point, although there was a significant 
increase in calorie intake in the HFD groups compared with the control group, we did not 
observe any caloric intake difference between the HFD and the HFD +EX groups (Fig. 2A and 
B). Energy expenditure, as measured by oxygen consumption over 24 h, was significantly 
increased in the HFD +EX group (5.32 ± 0.66 vs 4.72 ± 0.48 L/h/kg of lean mass) only during 
the night (Fig. 2C and D). Similarly, the total amount of carbon dioxide production over 24 h 
was also significantly increased in the HFD +EX group compared with the HFD group (3.92 ± 
0.62 vs 3.52 ± 0.39 L/h/kg of lean mass) only during the night (Fig. 2E and F). 
Long-term exercise training improves insulin sensitivity in HFD 
 To determine whether long-term voluntary exercise training can improve insulin 
sensitivity impaired by HFD, we measured both fasted and fed status glucose levels at 19 weeks 
of age. Although there was no significant difference in fasting plasma glucose levels between the 
HFD +EX and the HFD groups, fed plasma glucose levels in the HFD +EX group were 
significantly reduced compared with the HFD group (Fig. 3A and B). A glucose tolerance test 
also revealed that glucose tolerance was significantly improved in the HFD +EX group versus 




insulin tolerance test also showed improvement associated with exercise training, with peak 
differences after 15 and 30 min of the insulin injection. This indicates that long-term exercise 
training improves systemic insulin sensitivity (Fig. 3D). 
 In support of the notion that long-term exercise training improves systemic insulin 
sensitivity in the HFD+EX group, insulin signaling in skeletal muscle was examined by 
immunoblotting for phosphorylation of AKT (protein kinase B) in gastrocnemius. Figure 3E and 
F shows that skeletal muscle phosphorylation of AKT was significantly impaired in the HFD 
group compared with the control group (P < .05), and voluntary exercise training remarkably 
reversed skeletal muscle phosphorylation of AKT in the HFD+EX group, indicating that there is 
significant improvement in skeletal muscle insulin signaling (Fig. 3E and F). 
Voluntary exercise training reduces HFD-induced lipid accumulation in the liver and adipocytes 
size in white adipose tissue 
 Histological analysis shows that 12 weeks of HFD significantly increased lipid 
accumulation in the liver revealed by hematoxylin and eosin stain in liver sample sections, 
whereas voluntary exercise training remarkably reduced lipid accumulation in the liver (Fig. 4, 
left). In white adipose tissue, the cell size in HFD group mice was significantly increased 
compared with the control group; however, voluntary exercise training reduced the adipocytes 
size in the HFD+EX group (Fig. 4, right). 
Effect of long-term voluntary exercise training on HFD-impaired central leptin signaling 
 To determine whether the long-term voluntary running wheel exercise training can 
improve the hypothalamic function that controls energy metabolism, we measured leptin-induced 




the ARC and VMH was almost completely blunted (P < .05) in the HFD group compared with 
the control group (54 ± 3 vs 5 ± 1 counts per slice). Voluntary exercise training partially restored 
(P < .05) leptin-induced STAT3 phosphorylation in the HFD-treated mice (19 ± 2 vs 5 ± 1 counts 
per slice), suggesting that voluntary exercise training improves central leptin signaling (Fig. 5). 
Effect of long-term HFD and voluntary exercise training on POMC-expressing neurons  
 To determine the effect of HFD and exercise training on POMC-expressing neurons, 
immunolabeling with an anti-POMC antibody was assessed. It was found that 12 weeks of HFD 
significantly reduced (P < .05) the number of POMC neurons in the hypothalamus (26±3 counts 
per slice in the control group vs 16±2 counts per slice in the HFD group); however, long-term 
voluntary exercise training remarkably restored (P < .05) the number of POMC neurons in the 
HFD+EX group (23±2 counts per slice in the HFD+EX group vs 16±2 counts per slice in the 
HFD group; Fig. 6). 
Long-term voluntary exercise training restores HFD-damaged neuronal proliferation in the 
hypothalamus 
 To elucidate the potential mechanism of HFD- and exercise-induced POMC-expressing 
neuron alteration, an endogenous proliferative marker Ki67 was used to determine. neuronal 
proliferation. Under high-fat conditions, the Ki67- positive cells showed significantly decreased 
(P < .05) proliferation compared with the control group (8±1 counts per slice in the control group 
vs 2±2 counts per slice in the HFD group). It was found that 12 weeks of voluntary exercise 
training significantly restored (P  < .05) the loss of cell proliferation in the hypothalamus (4±1 
counts per slice in the HFD+EX group vs 2±2 counts per slice in the HFD group) (Fig. 7). Long-




in the hypothalamus. To further investigate the potential mechanism of HFD- and exercise 
induced POMC-expressing neuron alteration, TUNEL assay was performed to determine the 
neuronal apoptosis among the three groups (Fig. 8). Although there was no apparent cell  
apoptosis occurring in the ARC of the control group, 12-week HFD significantly increased (P < 
.05) cell apoptosis, especially in the ARC, and voluntary exercise training strongly protected 
against the HFD-induced apoptosis in this area (P < .05). Furthermore, the apoptosis that 
specifically occurred in the POMC neurons was reduced by more than half in the exercise 



















 In this study, we have demonstrated that exercise reduces apoptosis of POMC neurons in 
the ARC and reduces leptin insensitivity caused by diet-induced obesity.  Decreased dysfunction 
in this population occurs concurrently with improvement across skeletal muscle, liver, and white 
adipose tissue. At the whole body level, these exercise induced adaptations emerge as reduced 
adiposity and improved glucose regulation. 
 Although over the past decade we have gained a better understanding of CNS function in 
regulating food intake and body weight homeostasis33, 120, a gap of knowledge exists detailing 
how exercise training mechanistically induces weight loss via neurological control of energy 
balance and body weight in obese subjects. Given the facts, certain areas within the 
hypothalamus, such as ARC, VMH, DMH, and PVH, play important roles in regulating systemic 
metabolic homeostasis. However, to date, emerging evidence has shown that exercise training-
induced improvements are associated with molecular changes that improve metabolic functions 
in most peripheral tissues, such as increased glucose uptake in skeletal muscle and adipose tissue 
as well as decreased lipids accumulation in adipose tissue and the liver, all of which contribute to 
enhanced insulin sensitivity. Although there is an increasing amount of studies demonstrating 
that exercise training enhances the brain function, including the effects of exercise on learning 
and memory in hippocampal neurons, the role of exercise training in improving metabolic 
function via CNS-mediated pathways has not yet been fully understood. Thus, it is worthwhile to 
investigate the CNS-associated mechanism(s) of exercise training to improve metabolic function, 
particularly under diet-induced obesity conditions. In this study, we demonstrated that, first, 




through increased energy expenditure despite normal energy intake, and secondly, these effects 
may be associated with protection of POMC neurons and enhanced hypothalamic function 
response to leptin by voluntary exercise training under HFD conditions. 
 In the brain, POMC-expressing neurons are mainly located in the ARC of the 
hypothalamus and in the nucleus of solitary tract (NTS) in the brain stem. Genetically, when a 
null mutation of POMC gene is generated by targeting a gene in embryonic stem cell, 
hyperphagic and obesity phenotypes are displayed191. Human patients lacking POMC also 
confirm this obese phenotype18. Furthermore, a recent study has been published by Zhan and 
coworkers using the designer receptor exclusively activated by designer drugs system to 
selectively remove POMC-expressing neurons in these two areas. These researchers found that 
postnatal ablation of POMC neurons in the ARC nucleus (but not in the NTS) increased food 
intake, reduced energy expenditure, and ultimately resulted in obesity and metabolic and 
endocrine disorders193. Taken together, these findings indicate the importance and necessity of 
ARC POMC-expressing neurons in controlling whole-body homeostasis. An HFD rapidly 
induces neuron injury and eventually causes chronic inflammation in the hypothalamus, as 
confirmed by obese human subjects’ MRI data168. In the ARC, POMC-expressing neurons are 
specifically affected by an HFD96. We hypothesize, thus, that damage to a critical neuronal type 
(POMC) for body weight control might play a role in obesity, and exercise training may play a 
role to prevent the damage induced by a HFD. 
 POMC-expressing neurons control both energy intake and energy expenditure. One 
interesting finding of this study is that there is no food intake difference between the HFD and 




neurons significantly. This might be due to effects on counter regulators such as orexigenic 
agouti-related peptide (AgRP)-expressing neurons that also resides in the ARC. AgRP/NPY 
neurons control food intake, and ablation of AgRP neuron in adult mice has been shown to result 
in significantly reduced food intake101. It has also been reported that an HFD induces apoptosis 
of AgRP neurons113. These results suggest that long-term HFD and exercise training may have 
broad effects on both orexigenic and anorexigenic neurons in the ARC. Consistent with our 
findings, it has been reported that 6-week voluntary exercise training promotes leanness and 
prevents diet-induced obesity by increasing energy expenditure but not energy intake. These 
effects are associated with changes in the CNS centers that control energy homeostasis, 
particularly in the subset of neurons in the VMH, which is another primary satiety center in the 
hypothalamus, further proved the notion that exercise training may have broader effects than just 
particular neurons in the hypothalamus. In the same study, HFD-induced central leptin 
resistance, revealed by measuring food intake after central administration of leptin, was also 
significantly improved when followed by voluntary exercise training26. This suggests a potential 
mechanism of CNS-associated effects of exercise training on metabolic function. Our study 
further explored this notion by demonstrating central leptin signaling by immunolabeling 
phosphorylation of STAT3, a classic downstream pathway marker of leptin signaling 
transduction in the hypothalamus. We found that 12-week HFD treatment dramatically reduced 
pSTAT3 signals in the ARC and VMH nuclei, and that this impairment was significantly 
improved by voluntary exercise training. This was also true with even shorter periods of exercise 
training in diet-induced obese rats. Patterson and coworkers showed that 3 weeks of post-




induced obese rats, and that these effects are associated with increased leptin-induced pSTAT3 
expression in the ARC area 135. Leptin directly activates hypothalamic POMC-expressing 
neurons32, and deficiency of leptin signaling pathway activation in POMC-expressing neurons 
results in increased body weight9. 
 We investigated the effects of exercise training in POMC expressing neurons directly. A 
12-week HFD significantly decreased the number of POMC-expressing neurons, but this 
decrease was not observed in the HFD+EX group. To the best of our knowledge, this is the first 
study to show that voluntary exercise training has a beneficial role on POMC-expressing neuron 
turnover. Notably, turnover is the balance between neurogenesis and neuronal death. Most 
recently, neurogenesis has been described in the hypothalamus and has been shown to participate 
in the response of hypothalamic neuronal circuits to metabolic status79. Emerging evidence 
suggests that, in addition to the hippocampal area, active neurogenesis takes place in other 
regions of the adult rodent brain, including the hypothalamus, where a potential neurogenic niche 
has been identified. In adults, neurogenesis occurs at low rates in different areas of the brain. 
Moreover, the new neurons produced through adult life seem to contribute to physiological 
function of the entire body91. Neurogenesis in the ARC has shown to be essential for reducing 
and sustaining reduced body weight, and an HFD was shown to disrupt this neuronal 
proliferation process in mice with diet-induced obesity73, 110. To investigate the potential role of 
exercise in enhancing neuronal proliferation in the ARC that possibly promotes POMC-
expressing neurons, we measured the endogenous proliferative marker Ki67’s expression in the 
ARC area among the three groups. Consistent with previous findings, we found that 




very few Ki67-positive cells in the ARC area of mice in the control group; interestingly, there 
was a significant reduction of Ki67-positive cells in the same area of the HFD group. Voluntary 
exercise training significantly restored the Ki67-positive cells in the hypothalamus. However, 
one limitation of this study is that Ki67 can only be detected in premature cells, thus making it 
impossible to co-label along with mature cell markers to determine their final destination. 
Although we observed that there is a significant increase of Ki67-positive cells in the ARC of the 
HFD+EX group compared with the HFD group, the total net contribution to the increase of 
POMC-expressing neurons associated with reduction of body weight and adiposity remains 
mostly unclear. Future studies should address the specificity of exercise training-induced 
neuronal proliferation and weigh the contribution of these proliferative cells that regulate whole-
body metabolism. 
 Similar to our findings, Borg and coworkers have recently reported that 7 days of 
exercise training increased hypothalamic cell proliferation 3.5-fold above the sedentary mice. 
However, blocking cell proliferation via administration of the mitotic blocker cytosine-1-β-d-
arabinofuranoside (AraC) did not affect food intake or body mass in obese mice, indicating that 
the proliferation of new neurons is not required for maintaining whole-body homeostasis by 
exercise training17. Therefore, to elucidate the potential mechanism of nutrition and exercise 
training in altering POMC-expressing neurons, we next investigated neuronal death by using a 
TUNEL assay. It has been reported that overnutrition, such as a long-term HFD, could induce 
hypothalamic cell inflammation via endoplasmic reticulum (ER) stress, and inflammatory signal 
transduction can lead to the activation of apoptotic signaling pathways195. In contrast to the 




apoptosis occurring in the control group, in the HFD group we found that more cell apoptosis 
accumulated in the ARC area of the hypothalamus, and most strikingly, we also observed that 
voluntary exercise significantly reduced neuronal apoptosis compared with the HFD group, 
leading to a potential protective mechanism in which exercise training rescues HFD-induced 
neuronal loss. Along with our findings, Yi and coworkers have reported that 26 weeks of 
moderate treadmill exercise training prevented Western-style dietinduced hypothalamic 
inflammation by decreasing microglia activation in the ARC, supporting the idea of exercise 
training in repairing neuronal damage in the hypothalamus192. The possible molecular 
mechanism of HFD-induced ER stress might be associated with IKK-β/NF-κB pathway in the 
hypothalamus, which an HFD could activate leading to a progression of ER stress in the 
hypothalamus and therefore impairing insulin and leptin signaling, thus resulting in energy 
imbalance195. Thus, IKK-β/NF-κB in the hypothalamus is a potential target pathway for exercise 
training-associated benefits in the hypothalamus. Interestingly, interleukin 6 (IL6) is a cytokine 
that has both proinflammatory and anti-inflammatory functions along with its metabolic effects 
on food intake suppression, energy expenditure induction, and body weight and adiposity 
reduction. The actions of IL6 might mediate to suppression of IKK-β/NF-κB activation in the 
hypothalamus and thus help to maintain normal function194. Notably, the IL6 is a highly exercise 
inducible cytokine in skeletal muscle (during contraction) as well as in neurons located in the 
hypothalamus. Indeed, the increased hypothalamic IL6 expression was observed in exercise 
trained rats194, suggesting a possible molecular mechanism that exercise improves metabolic 
function at least partially via the IL6-IKK-β/NF-κB/ER stress-mediated pathway, thus preventing 




element that influences neuronal survival and differentiation15 and has a strong metabolic 
function in regulating body weight187. It has been reported that HFD reduces hippocampal levels 
of BDNF111. Interestingly, BDNF can be induced in the CNS by exercise and exercise training112, 
111, leading us to suspect that BDNF also plays an important role in protecting neurons from 
HFD-induced damages in the hypothalamus, which might be further enhanced by exercise 
training. Taking these facts together, it would be intriguing to investigate the relationship 
between exercise-induced hypothalamic IL6 and BDNF signaling in conjunction with 
hypothalamic function in the context of energy homeostasis. 
 Overall, this study has demonstrated the effects of voluntary exercise training on 
metabolic function that may be associated with CNS-mediated pathways by protecting POMC-
expressing neurons and enhancing leptin signaling in the ARC nucleus of the hypothalamus. 
Although the cellular and molecular mechanisms behind this phenomenon need to be explored 
further, our findings regarding CNS-mediated pathways that potentially mimic the effect of 
exercise training to prevent hypothalamic neuron loss would make a highly logical and desirable 
strategy for the prevention and treatment of obesity in humans. 



























































Figure 2.1 Chronic voluntary wheel running reduces high fat diet induced obesity and 
adiposity. (A) Locomotion behavior indicated by count data of beam breaks. (B) Running wheel 
distance traveled. (C) Body weight (grams) at the start of experiment. (D) Body weight (grams) at 
the end of the experiment. (E) Fat mass between groups. (F) Lean mass between groups at the end 
of experiment. (G) Epididymal fat mass (grams) at the end of the experiment. (H) Perineal fat 
mass (grams) at the end of experiment. (I) Mesenteric fat mass (grams) at the end of experiment. 






Figure 2.2 Energy intake and expenditure between chow, HFD, and HFD + Exercise groups. 
(A) Daily caloric intake between groups. (B) Weekly caloric intake between groups. (C) Energy 
expenditure as indicated by volume of oxygen consumption.  (D) Oxygen consumption by light 
cycle. (E)  Gas exchange as measured by carbon dioxide production. (F) Carbon dioxide production 





 Figure 2.3 Exercise improves glucose tolerance and insulin sensitivity. (A) Fasting glucose 
levels. (B) Fed glucose levels. (C) Glucose tolerance test after intraperitoneal glucose injection. 
(D) Insulin tolerance test after intraperitoneal insulin injection. (E) Serine 473 phosphorylation of 
AKT (Protein Kinase B) after saline (-) or insulin (+) injection. (F) Relative change is 
phosphorylated AKT compared to chow group after saline administration. * indicates significance 







Figure 2.4 Exercise improves liver and adipose tissue morphology. (A) Liver lipid droplet 





Figure 2.5 Exercise improves high fat diet induced hypothalamic leptin insensitivity. (A) 
Representative images of cells positive for phosphorylation STAT3 between chow, HFD, and 
HFD+Ex. Scale bars are 50µm. (B) Quantification of leptin induced phosphorylation of 







Figure 2.6 Exercise partially restores HFD induced loss of POMC neuron number. (A) 
Representative images of POMC neurons (red) and nuclei (blue) for chow, HFD, and HFD+Ex. 
Scale bars are 50µm. (B) Quantification of POMC neuron number. * indicates significance 





Figure 2.7 Exercise partially restores HFD induced suppression of proliferation. (A) 
Representative images of Ki67 positive cells (green) and nuclei (blue) for chow, HFD, and 
HFD+Ex. Scale bars are 100µm. (B) Quantification of Ki67 positive cells. * indicates 





Figure 2.8 Exercise prevents POMC neuron apoptosis. (A) Representative images of POMC 
neurons (red) and apoptotic cells (green) for chow, HFD, and HFD+Ex. Scale bars are 100µm. 
(B) Quantification of Ki67 positive cells. * indicates significance compared to chow, # 





AgRP/NPY Neuron Mediated Hunger is Modulated by Metabotropic Glutamate Receptor 1 
During Fasting 
 
Abstract: The potential to control feeding behavior via hypothalamic AgRP/NPY neurons has led 
to many approaches to modulate their excitability – particularly by glutamatergic input. In the 
present study using NPY-hrGFP reporter mice, we identify AgRP/NPY neuronal metabotropic 
glutamate receptor 1 (mGluR1) expression and test the effect of fasting on mGluR1 function. In 
the first experiment, we show in vivo that blocking metabotropic glutamate receptor 1 by 
antagonist 3-MATIDA lowers fasting induced refeeding. Using the same antagonist, we 
demonstrate ex vivo that enhanced mGluR1 function on AgRP/NPY neurons occurs as part of a 
normal physiological response to fasting. Conversely, using the pharmacological agonist 
dihydroxyphenylglycine (DHPG) we demonstrate the enhanced capacity of mGluR1 to drive 
firing of AgRP/NPY neurons after overnight fasting. Further, under synaptic blockade we 
demonstrate that DHPG acts directly on AgRP/NPY neurons to create a slow inward current.  
Using an in vitro approach, we show that emulation of intracellular signals associated with 
fasting by forskolin enhances mGluR1 induced phosphorylation of Extracellular Regulated-
















 AgRP/NPY neurons release potent regulators of food seeking behavior171 that respond to 
energy deficit 148,101 due to changes in circulating factors34. In addition, many pre-synaptic 
sources of glutamate contribute to the excitability of AgRP/NPY neurons84, 99, particularly under 
the fasted condition.  Fasting induces activation of Protein Kinase A (PKA) in arcuate 
AgRP/NPY neurons122, 152. PKA enhances function of mGluR1to increase IP3 accumulation48 
and promotes surface stability of mGluR1 by preventing internalization induced by arrestin2 and 
G-protein receptor kinase 2118. While previous reports found no detectable function of mGluR1 
by agonist dihydroxyphenylglycine (DHPG) on AgRP/NPY neurons in fed mice127, a gap in 
understanding exists regarding if energy deficit can switch on mGluR1 in AgRP/NPY neurons. 
 G-protein coupled receptor (GPCR) metabotropic glutamate receptor 1 (mGluR1) mRNA 
is expressed across the adult brain such as hypothalamus, hippocampus, globus pallidus, 
substantia nigra, thalamus, olfactory bulb, cortex, cerebellum, and brain, while mGluR1 protein 
is expressed mostly in cerebellum, olfactory bulb, and hypothalamus176. mGluR1’s are primarily 
concentrated on post-synaptic structures60 to depolarize the neuron by enhanced inositol-3-
phosphate driven release of sequestered intracellular calcium from endoplasmic reticulum. 
Controversy exists over the presence and function of mGluR1 in the arcuate nucleus of the 
hypothalamus176, 60, 75, 109.   
 Disorder of excitatory synaptic transmission via metabotropic glutamate receptors 
contributes to nervous system diseases ranging from chronic pain, cancer, autism, schizophrenia, 
Alzheimer’s disease, Parkinson’s disease, neuroinflammation, multiple sclerosis, epilepsy, 
stroke, obesity and diabetes – the diversity of these diseases owed to the broad regional 




to manipulate mGluR1 have yielded limited results for treatment of epilepsy, pain, Alzheimer’s, 
Parkinson’s, anxiety/depression60. By understanding the metabolic mediators that influence 
mGluR1 function, new approaches targeted at enhancing effectiveness of mGluR1 modulation 
could hold the potential to be a new frontier for treatment of a broad range of disorders.  
 Here, we demonstrate a functional excitatory role of metabotropic glutamate receptor 1 
mGluR1 on AgRP/NPY which drives refeeding after the fasted state. Antagonism of mGluR1 
lowers fasting induced refeeding. We show that fasting increases AgRP/NPY neuron response to 
DHPG, while there is no effect on AgRP/NPY neurons of fed mice.  Similarly, in GT1-7 
hypothalamic cells, forskolin stimulation facilitates DHPG induced phosphorylation of ERK. 
Taken together, our data indicate that neuronal excitability by mGluR1 occurs secondarily to 
















 Animal housing  
B6.FVB-Tg(NPY-hrGFP)1Lowl/J mice were individually housed in accordance with National 
Institutes of Health Guide for the Care and Use of Laboratory Animals (National Institutes of 
Health Publication no. 85-23, revised 1996) an approved by the Institutional Animal Care and 
Use Committees of East Carolina University.  
Fasting induced refeeding  
Overnight fasting was conducted by placing animals in a fresh cage without food while fed 
animals were moved to a fresh cage and given food ad libitum. Alpha-dry bedding was used to 
prevent consumption of bedding during the fast. Food was removed between 5:00PM-7:00PM. 
On the subsequent day, animals were injected with 21.5µG of α-Amino-5-carboxy-3-methyl-2-
thiopheneacetic acid (3-MATIDA) dissolved in DMSO by intracerebroventricular administration 
at 7:30AM (start of light phase) and food was presented at 8:00AM. This dose is the maximum 
solubility of 3-MATIDA that can be delivered within 2µl of administration, approximating to 
1mg/kg117. Control animals received DMSO as vehicle control. 
Intracerebroventricular cannulation  
 Mice were administered analgesic meloxicam and anesthetized with ketamine and xylazine. 
Mice were then cannulated for delivery of drug to lateral ventricle by intracerebroventricular 
cannulation. After a midline incision and orientation to the bregma, stereotaxic coordinates (-
.5mM posterior, 1mM lateral, 2.5mM depth) were used for placement of a sterilized cannula and 
mice were included if placement was visually verified to the lateral ventricle by after sacrifice. 




structure and at the contralateral ventricle. 3M carboxylate dental cement was used to secure the 
implants to the skull.  
Immunofluorescence 
We conducted immunofluorescent analysis as previously described86. Briefly, at least 3 closely 
matched sections were used for at least 3 mice in each group. Slices were washed in PBS and 
blocked in PBS with triton (.3%). Slices were incubated overnight in primary antibody. On the 
subsequent day, slices were washed and incubated in secondary antibody. After 90 minutes, 
slices were washed and mounted for fluorescent microscopy. Co-localization was manually 
determined by overlaying images and using cell counter plug-in on ImageJ. For imaging of 
mGluR1, a set of stains was also conducted without any primary antibody to verify that detection 
was above background levels. The mean value of no primary control images was subtracted from 
all images prior to calculation of Manders Overlap Co-efficient using ‘Just Another Co-
localization’ plug-in. 
Epifluorescence microscopy  
cFOS and pERK co-localization with AgRP/NPY neurons was imaged using Leica DM6000FS 
epifluorescent microscope. Images for each marker were obtained with equal exposure, 
saturation, gain, gamma and shutter intensity. Representative images were treated with identical 
corrections. 
Confocal Microscopy  
Sections were imaged using an Olympus FV1000 laser scanning confocal microscope (LSCM). 
Acquisition software was Olympus FluoView FSW (V4.2). The objective used was 60X oil 




pixel with 2us/pixel dwell time. Detector noise was reduced by application of a 3X line scanning 
kalman filter. Images were acquired in sequential scan mode. Dapi was excited using the 405nm 
line of a multiline argon laser, emission was filtered using a 490nm dichroic mirror and 430-
470nm barrier filter. GFP was excited using the 488nm line of a multiline argon laser, emission 
was filtered using a 560nm dichroic mirror and 505-540nm barrier filter. Alexafluor 594 was 
excited using a 559nm laser diode, emission was filtered using a 575-675nm barrier filter. 
Standardized laser power and detector gain settings were determined using test sections and zero 
detector offset was used for all images. Lateral optical resolution was .196um, and axial optical 
resolution was .902um. The pinhole aperture diameter was set to 105um (1 Airy disc).  A 3X 
digital zoom was applied to all images used for colocalization analysis to ensure adequate 
sampling. Lateral pixel size was .088um/pixel, and axial pixel size was .390um/slice. Image 
processing was performed using ImageJ (V1.51f). Representative images were treated with 
identical corrections. 
Patch clamp electrophysiology  
We conducted cell attached voltage clamp recordings of AgRP/NPY neurons. Briefly, before 
10:00AM mice were deeply anesthetized by isoflurane followed by intracardial perfusion with 
chilly n-methyl-D-glucamine solution (in mM: 92 NMDG, 2.5 2.5 KCl, 1.25 Nah2PO4, 30 
NaHCO3, 20 HEPES, 25 Glucose, 2 Thiourea, 5 Na-Ascorbate, 3 Na-Pyruvate, .5 CaCl2, 10 
MgSO4 ) and sliced into 200-300μM using VF200 Compresstome (Precisionary Instruments, 
Greenville NC). Slices recovered for an hour and were stored for recording in a BSK6 
(Automate scientific, Berkley CA) in HEPES solution (in mM: 92 NaCl, 2.5 KCl, 1.25 




CaCl2, 2 MgSO4). Recordings were conducted in normal aCSF (in mM: 119 NaCl, 2.5mM KCl, 
1.25mM NaH2PO4, 24 NaHCO3, 12.5 Glucose, 2 CaCl2*H2O, 2 MgSO4) on a bath. Neurons 
were visualized using Leica DM6000FS microscope with polarized differential interference 
contrast microscopy using infra-red illumination and fluorescent imaging (488nM). Using 3-
7mOhm pipettes, cell-attached seals were obtained. For cell attached recordings to detect firing 
rate, gain was modified to enhance signal/noise ratio for clear detection of action potentials and 
holding potential was set to -50mV. Seals were stabilized and a 3-5 minute baseline period was 
recorded followed by perfusion of dihydroxyphenylglycine (DHPG) (50μM). Firing rates were 
counted only during recording periods where action potential amplitude exceeded any change in 
voltage using clampfit threshold counter. Equivalent length periods (.5-5minute) were set within 
each recording during perfusion of aCSF or DHPG. Firing rate (Hz) was calculated from 
dividing the number of events by the number of seconds. For whole cell recordings, gigaohm 
seals were obtained and the cells were broken into using negative pressure and signals were 
stabilized before any analysis periods. Current clamp recordings were stabilized for repeated 
firing under baseline condition. Voltage clamp whole cell recordings were conducted at a -60mV 
holding potential.  
Cell Culture 
Immortalized hypothalamic GT1-7 cell culture were raised in Dulbecco’s Modified Eagle 
Medium. GT1-7 cells were pre-treated (1.75hr) with standard media alone, media with adenylyl 
cyclase stimulant forskolin (10μM), or media and forskolin (10μM). Next, we remade pre-
treatment mix with or without mGluR1 agonist DHPG (50μM) and applied to cells (.25hrs). 




was determined using Pierce bicinchoninic acid assay (BCA) (ThermoFisher Scientific). 
Samples were standardized by adding equal amount of protein and 4x loading buffer combined 
with variable volume of by lysis buffer for western blot. Due to limitations in protein, 
phosphorylated ERK was averaged across 4 experiments and total ERK, which was quite stable 
across conditions, was averaged across two independent experiments.  
 Western Blot: Equal protein content mixtures were loaded into 4-20% HCL gel then 
transferred to nitrocellulose membrane.  Membrane strips were incubated overnight in 1:1000 
diluted antibody in 5% milk for pERK (Cell Signaling Technology), total ERK. Samples were 
incubated for 2 hours in secondary antibody followed by ECL treatment and imaging with 
Chemidoc. Using ImageJ, images were inverted and mean intensity of equal-area selections was 
measured from each lane and a blank spot on the strip (background). Background was subtracted 
from mean intensity of each lane. Mean phosphorylated ERK was calculated across four 
different sets of experiments, while total ERK was conducted across two independent 
experiments. 
Statistical analysis 
2-way repeated measures ANOVA with Sidak correction for multiple comparisons was used to 
analyze food intake across refeeding period. Paired t-tests were used to determine differences 
between firing rate under aCSF and DHPG treatment, while unpaired tests were used for 
comparisons between fed and fasted neurons as well as for western blots. Statistical significance 







Hypothalamic AgRP/NPY neuron mGluR1 expression 
 We searched for the presence of mGluR1 on AgRP/NPY neurons using overnight fasted 
NPY-hrGFP mice. Manders Overlap Coefficient reveals that AgRP/NPY neurons predominantly 
express mGluR1 in non-nuclear subcellular locations (.0685±.011) compared to nuclear 
localization marked by DAPI (.035±.002) (Figure 3.1). Both regions had detectable 
immunoreactivity relative to no primary control (.003±.000) Previous reports show hypothalamic 
mGluR1a/b75, 60,and single cell transcriptome analysis demonstrate that AgRP/NPY neurons 
express GRM158.  To our knowledge this is the first visualization of mGluR1 on hypothalamic 
AgRP/NPY neurons.  
Forskolin enhances mGluR1 function in GT1-7 hypothalamic cells 
 We selected adenylyl cyclase stimulant forskolin to mimic fasting induced AgRP/NPY 
neuron intracellular signals. Given the utility of ERK1/2 activity as a readout for Gq Protein-
Coupled Receptor manipulation130, we tested for the effect of mGluR1 agonism by DHPG 
(1.35±.026) with and without forskolin pre-treatment (.7976±.022) compared to control 
(.9031±.021) and forskolin alone (1.11 ± .013). We show in vitro that pre-treatment with 
forskolin enhances mGluR1 function by DHPG-induced phosphorylation of ERK1/2 (p < .05) 
(Fig 3.2). Of note, treatment with DHPG alone did not alter pERK1/2. This data clearly 
demonstrates conditional functionality of mGluR1. 
Fasting enhances AgRP/NPY responsiveness to mGluR1 agonist dihydroxyphenylglycine 
 Using cell attached recordings of AgRP/NPY neurons, we confirmed that mGluR1 




mice under the fed status (1.36±.237) (n = 12) (Figure 3.3A), but notably DHPG enhanced firing 
rate (4.58±.971) of AgRP/NPY neurons from mice under the fasted condition (2.62±.556) (n = 
11) (Figure 3.3B). No observable effect of DHPG on AgRP/NPY neurons from fed mice is 
consistent with a previous report that there is no change in AgRP/NPY membrane potential by 
DHPG95.  Notably, mGluR1 function after fasting can enhance neuronal firing of AgRP/NPY 
neurons even beyond the typically high fasting-induced firing rate. Because this pharmacological 
stimulation well exceeds normal glutamatergic inputs available to mGluR1, this strongly 
suggests that mGluR1 has the capacity to drive excitability under appropriate conditions.  
mGluR1 antagonism reveals contribution to AgRP/NPY neuron activation during fasting  
 Bath application of mGluR1 antagonist 3-MATIDA (100µM) reduces AgRP/NPY firing 
rate (p < .05) (Figure 3.4) from brain slices (n = 11) of fasted mice. Because loss of mGluR1 
function results in slowed firing (.2688±.078) compared to aCSF alone (.7245±.166), this data 
indicates mGluR1 contributes to increased fasting induced firing rate. This may co-occur with 
ionotropic glutamatergic function as reported elsewhere99. 
mGluR1 induces a slow inward current in AgRP/NPY neurons under synaptic blockade 
 Using whole cell voltage clamp recordings from AgRP/NPY neurons of fasted mice, we 
employed an ionotropic synaptic blockade with AP5, CNQX, and picrotoxin prior to perfusion 
of DHPG (Figure 3.5). Once isolated, DHPG perfusion results in slow excitatory currents 
(Figure 3.5B) in a subset of AgRP/NPY neurons (n = 4/16). Compared to blockade alone 
(.4393±1.614), DHPG induces a slow inward current (-16.22±5.34).The slow current observed 
occurs over the timescale of minutes as previously described under previous measurements of 




than 10pA, which is a physiologically relevant influence on small neurons such as AgRP/NPY 
neurons11. 
mGluR1 antagonism reduces fasting induced refeeding 
 Next we investigated for a physiological function of mGluR1 on AgRP/NPY neurons.  
Based on the excitatory action of mGluR1 and the established role of AgRP/NPY neurons to 
control food seeking behavior during fasting, we tested the effect of mGluR1 antagonism during 
a fasting induced refeeding assay. Compared to DMSO control (.224±.038), central 
administration (n = 5) of mGluR1 antagonist 3-MATIDA reduces food intake (.066±.025) at the 
60-90 minute mark during fasting induced refeeding (p < .05) (Figure 3.6). However, compared 
to DMSO control (.972±.058) this change was not substantial enough to alter cumulative food 
intake over two hours (.79±.098). Given that AgRP/NPY neurons are essential for ghrelin to 
drive feeding behavior28, it is notable that this time coincides with reported decreases in ghrelin 
levels and our observed central effect by 3-MATIDA52. 
Fasting induced AgRP/NPY activation and phosphorylation of Extracellular Signal-Regulated 
Kinase  
 Next, we tested for immunoreactivity of pERK1/2 and cFOS in AgRP/NPY neurons of 
fed and fasted mice. We observe that in AgRP/NPY neurons of fasted mice, increased (p < .05) 
localization of neuronal activation marker cFOS (Fig 3.7A) and phosphorylation of ERK1/2 (Fig 
3.7B). This suggests that factors contributing to phosphorylation of ERK1/2, including mGluR1, 
may be enhanced as part of the activation response to fasting. While previous reports 






























 In the present study, we demonstrate that overnight fasting enhances function of metabotropic 
glutamate receptor 1 (mGluR1) on AgRP/NPY neurons in the hypothalamus, and that central 
antagonism of this receptor reduces refeeding behavior. Many previous reports have detailed the 
influence of hormonal19, 83, intracellular signals189, 123 and synaptic alterations174, 182 that occur in 
AgRP/NPY neurons in response to fasting150. Here we relate fasting induced intracellular signals 
of AgRP/NPY neurons with enhanced post-synaptic mGluR1 function (Figure 8).  
 Despite multiple reports of mGluR1detection in medial basal hypothalamus 109, 58 to our 
knowledge, this report is the first to visualize mGluR1 localization specifically on AgRP/NPY 
neurons. Expression of mGluR1 is consistent with the presence of mRNA for GRM158. 
Interestingly, while fasting does not alter GRM1 mRNA, we observe that mGluR1 
immunoreactivity is enhanced. This discrepancy could be due to changes in translation rates, 
trafficking to subcellular locations more available to antibody binding, or a reduction in mGluR1 
degradation. Given that this finding is limited to the quality of the mGluR1 antibody used in this 
study, control stains were conducted on slices that did not get treated with primary antibody.  
 mGluR1 antagonism with central administration of 3-MATIDA has a profound blunting 
effect on re-feeding behavior at a 60 to 90 minute time point. Within the first 60 minutes of re-
feeding after an overnight fast, ghrelin is a dominant driver of hunger, but previous reports 
demonstrate that by minute 60 circulating ghrelin levels have waned52. Decreased availability of 
ghrelin results in a smaller pool of activated AgRP/NPY neurons. Once the pool of AgRP/NPY 
neurons falls below a critical point of around 800 into the 300-700 range or the 0-100 range164, 




modulator of AgRP/NPY excitability to maintain the pool of activated AgRP/NPY neurons 
above threshold required to drive feeding. Loss of this excitatory drive by antagonism of 
mGluR1 results in reduced hunger that becomes apparent as reduced feeding behavior. While the 
antagonistic approach by 3-MATIDA yielded valuable information regarding reduction of food 
intake via reduced mGluR1 activity, one major limitation to studying mGluR1 is that central 
mGluR1 agonism leads to severe epileptic activity169.  
 In AgRP/NPY neurons of fasted mice, ex vivo experiments with antagonist 3-MATIDA 
revealed a reduction in neuronal firing rate compared to aCSF. This effect establishes a 
physiological role of mGluR1 to contribute to fasting induced firing rate of AgRP/NPY neurons. 
A reduction of firing by AgRP/NPY neurons indicated that 3-MATIDA may have a role in 
reducing feeding. 
 Conversely, AgRP/NPY neurons exhibit responsiveness to metabotropic glutamate 
receptor 1 agonist dihydroxyphenylglycine (DHPG). Consistent with previous reports, we show 
that DHPG agonism has no detectable effect on AgRP/NPY neurons of fed mice126. This finding 
demonstrates that fasting enhances the capacity of mGluR1to mediate AgRP/NPY neuronal 
firing under physiological conditions in response to pharmacological stimulation. At this time it 
is unclear if this is due to a post-translational modification or directly related to our observation 
of enhanced immunoreactivity.  
 Consistent with visual evidence of mGluR1 on AgRP/NPY neurons and the observed 
change in firing rate, we report functional post-synaptic effects of DHPG directly on AgRP/NPY 
neurons. Voltage clamp electrophysiology revealed a DHPG-induced slow excitatory post-




blockade, similar to the slow-current observed in mitral cells56, 117. Given reports that a 10pA 
change to the rheobase of small neurons like AgRP/NPY neurons can result in substantial 
changes to their level of activation11, this slow current is profound enough to influence 
excitability of AgRP/NPY neurons in a physiologically relevant way.  
 A number of groups have reported PKA activation in AgRP/NPY neurons of mouse 
hypothalamus during fasting122, 174, 115 and that forskolin stimulates AgRP transcription in GT1-7 
cells via PKA activation122. Further, PKA activation is critical for the calcium response to 
ghrelin78. As a synaptic modulator, PKA is known enhance AMPAR trafficking64 and to blunt 
function of inhibitory metabotropic glutamate receptors148. Notably, in HEK293 cells transfected 
to express mGluR1, forskolin enhances mGluR1 response to glutamate48, likely by preventing 
internalization of mGluR1 by reducing association with G-protein coupled receptor kinase 2 and 
arrestin 2118. Thus, we used forskolin to mimic the fasting induced intracellular signals and this 
resulted in enhanced mGluR1 induced p-ERK. This effect isn’t explained by simple addition of 
forskolin or DHPG treatment. This in vitro experiment is consistent with enhanced function of 
mGluR1 in hypothalamic neurons in concordance with increased Protein Kinase A activity and 
phosphorylation of ERK during the fasted state. Of note, while forskolin is a classic adenylyl 
cyclase stimulant, it also enhances ERK phosphorylation. Given that ERK1/2 can also potentiate 
mGluR1 function188, future studies should tease out if there is a dominant intracellular stimulus.  
 We observe enhanced positive cell counts for cFOS and phosphorylation of ERK in 
AgRP/NPY neurons of fasted mice. While it is unclear at this time what the physiological 
sources or role of this ERK phosphorylation is, mGluR1 appears to be one contributor. Co-




AgRP/NPY neurons may reflect some relationship between the two and would be consistent 
with mGluR1 activation during fasting. However, this effect is in stark contrast to previous 
reports of FGF induced phosphorylation of ERK1/2 in inactivated AgRP/NPY neurons106 and 
known roles of ERK to inhibit AgRP transcription mediated by KLF4132. The ability of mGluR1 
to simultaneously drive firing and ERK phosphorylation marks a distinction from receptors with 
tyrosine kinase activity. Sorting out the discrepancy between activation and ERK 
phosphorylation warrants future investigation. We suggest a glutamatergic system capable of 
facilitating action potential induced release of AgRP filled vesicles and simultaneously slowing 
production of new AgRP – a neuronal phenomenon which would correspond to whole body 
satiation if the neurons are not also under the influence of ghrelin. This model would be 
consistent with the timing of the effect we observe by mGluR1 antagonism on feeding behavior.   
Conclusion 
 In summary, our results demonstrate expression and function of mGluR1 on AgRP/NPY 
neurons that contributes to feeding behavior. Our results demonstrate an approach to hunger 
control via AgRP/NPY neuron excitability through intracellular signals that influence 

































     
 
 
Figure 3.1 AgRP/NPY Neurons Express mGluR1a/b. (A) Representative images of mGluR1 
a/b (red) expressing AgRP/NPY (green) neurons (left), close apposition of mGluR1 (red) to the 
nucleus of AgRP/NPY neurons (blue) (middle), and mGluR1 staining alone (grey) (right). (B) 
Representative images of no primary control stains (red) on AgRP/NPY neurons (green) (left), 
nuclei (blue) (middle), and no primary control grey scale (right). (C) Manders overlap 
coefficients for the proportion of cytosol/membrane covered by mGluR1a/b, nucleus covered 










Figure 3.2 Forskolin enhances mGluR1 function. (A) Representative images of western blots 
for phosphorylation of ERK (1/2) and total ERK (1/2) (B) Bar graph of mean intensity for 
phosphorylated ERK (1/2) (n = 4) normalized to total ERK (n = 2). Student’s t-test used for 
















Figure 3.3: Group I metabotropic receptor agonist dihydroxyphenylglycine (DHPG) 
enhances firing rate of NPY/AgRP neurons specifically under the fasted condition. (A) 
Representative trace showing neuronal firing of AgRP/NPY neuron from a fed mouse under 
aCSF and DHPG. (B) Representative trace showing neuronal firing of AgRP/NPY neuron from 
fasted mouse under aCSF (middle left) and DHPG (middle right). (C) Bar graph (bottom left) 
of mean firing rate. (D) Dot plot of each individual neuron (bottom right). Standard t-test used 
to compare across fed and fasted conditions, matched pairs t-test used for detection of within 
condition differences. Means ±SEM (n = 11 fed; n = 12 fasted). Bar graph significance marked 

















Figure 3.4: mGluR1 antagonist 3-MATIDA slows firing rate of NPY/AgRP neurons from 
fasted mice. (A) Representative whole cell recordings of neuronal firing of AgRP/NPY neuron 
from a fed mouse under aCSF and 3-MATIDA. (B) Bar graph of mean firing rate. (C) Dot plot 
of each individual neuron. Matched pair t-test used to compare across fed and fasted conditions. 








Figure 3.5: A subset of AgRP/NPY neurons under synaptic blockade exhibit a slow 
inward current in response to Group I Metabotropic Receptor Agonist 
Dihydroxyphenylglycine. (A) Representative whole cell voltage clamp recording of an 
AgRP/NPY neuron that does not respond to DHPG. (B) Representative whole cell voltage 
clamp recording of an AgRP/NPY neuron in response to DHPG.  (C) Bar graph of proportion 
of AgRP/NPY neurons from fasted mice that are DHPG responders (4/16). (D) Bar graph of 
current change from previous condition. Matched pair t-test to compare blockade and blockade 





   
 
 
Figure 3.6: Central administration of mGluR1 antagonist 3-MATIDA reduces fasting 
induced refeeding. (A) Food intake values over two hours of refeeding broken into 30 minute 
epochs. (B) Cumulative food intake values over two hours. Two way ANOVA with Sidak 




      




Figure 3.7: Fasting induces cFOS and phosphorylation of ERK1/2 in AgRP/NPY neurons. 
(A) Representative images of cFOS (red) and NPY/AgRP neurons (green) under fed and fasted 
conditions. (B) Representative images of pERK (red) and NPY/AgRP neurons (green) under 
fed and fasted conditions. (C) Count data for mean AgRP/NPY neurons per slice and mean 
number of AgRP/ neurons co-localized with cFOS. (D) Count data for mean AgRP/NPY 
neurons per slice and mean number of AgRP/NPY neurons co-localized with pERK.  Bar 









Chapter 4: Summary and Conclusions 
 In modern western society with rampant energy surplus due to excess consumption of 
calorie dense foods and lack of activity, diseases related to energy surplus have reached epidemic 
proportion. As a critical node in the control of whole body energy balance, the ARC holds the 
potential to reverse or slow progression of many diseases. The purpose of this dissertation was to 
address adaptations of the ARC in response to two methods of energy surplus reduction; 1) 
increased energy expenditure and 2) reduced energy intake.  
 The ARC houses many critical populations of neurons that regulate energy balance. Two 
of these populations, known as POMC and AgRP/NPY neurons have been referred to as the 
yin/yang of energy balance199. POMC neurons reduce energy surplus by inducing satiety and 
increasing energy expenditure. Conversely, AgRP/NPY neurons increase feeding and lower 
energy expenditure. As effectors, these neuron populations co-regulate downstream targets such 
as the melanocortin receptor expressing neurons. As sensors, these neurons receive hormonal and 
neural inputs from sources throughout the body. In order to investigate the potential for increased 
expenditure and decreased intake to influence adaptations within the arcuate nucleus, two 
independent studies were conducted whereby we tested the hypotheses that 1) increase in energy 
expenditure by voluntary wheel running will result in improved hypothalamic hormone signaling 
and reduced POMC neuron turnover, and 2) decrease in energy intake by overnight fasting will 
result in enhanced mGluR1 mediated excitatory input onto AgRP/NPY neurons.  
 Taken together, this dissertation addresses a subset of adaptations that occur within the 
arcuate nucleus of the hypothalamus in response to common methods for reducing energy 
surplus (Figure 4.1). The data within this dissertation clearly demonstrate that 1) the damaging 




and 2) hunger drives feeding behavior via enhancement of mGluR1 mediated AgRP/NPY 
neuronal excitability. 
Exercise Reverses the Damage of Diet-Induced Obesity 
 We assessed if exercise reverses the damage of DIO to the ARC of the hypothalamus and 
peripheral organ systems. In DIO mice, voluntary exercise reduces bodyweight by decreasing fat 
mass (Figure 2.1). This decrease in fat mass is driven by increased energy expenditure without a 
change in food intake (Figure 2.2). Thus, exercise may serve as a viable treatment for the 
hallmark of obesity. In addition, exercise improves glucose tolerance and reduces insulin 
resistance – particularly at skeletal muscle (Figure 2.3). Along with these changes, exercise 
improves the morphology of liver and white adipose tissue evidenced by reduced lipid droplet 
accumulation and reduced adipocyte size (Figure 2.4). This suggests adaptation to substrate 
availability and lipid handling by reduced storage or increased oxidation. The reduction in 
adiposity likely contributes to reduced hyperleptinemia12, which permits hypothalamic sensitivity 
to leptin and promotes ARC signaling via the leptin receptor indicated by phosphorylation of 
STAT3 (Figure 2.5).  Blunted leptin signaling in the ARC is sufficient to induce obesity31, thus 
reversal of this DIO phenomenon provides substantial justification towards the use of exercise as 
a therapy for obesity. Further, DIO leads to apoptosis of POMC neurons113, while experimental 
loss of POMC neurons results in obesity53. Therefore, preservation of the number of POMC 
neurons in the population can have a profound effect on improvement of whole body energy 
balance. In our study, we demonstrate preservation of POMC neuron number by exercise (Figure 
2.6) due to reduced apoptosis (Figure 2.7) which occurs under DIO in sedentary animals.  




 Hunger promotes food-seeking behavior, primarily through activation of AgRP/NPY 
neuron84, 150. Many hormonal and neural factors contribute to activation28, 86 or disinhibition 92, 11 
of AgRP/NPY neurons. We demonstrated that AgRP/NPY neurons express mGluR1a/b in the 
cytosol and membrane (Figure 3.1) despite evidence that suggests that mGluR1 has little 
influence on depolarization of AgRP/NPY neurons127 from fed mice. However, the intracellular 
milieu of AgRP/NPY neurons becomes markedly different during fasting, whereby an 
accumulation of cAMP drives activation of PKA48, 118. Given the known role of PKA to facilitate 
synaptic stability of excitatory ionotropic AMPA receptor while inhibiting Gi linked 
mGlur2/3148, we used an in vitro model to test the impact of forskolin pre-treatment on the 
function of mGluR1 in immortalized hypothalamic cells. Consistent with our hypothesis, 
forskolin pre-treatment enhances the response to group I metabotropic receptor agonist DHPG 
(Figure 3.2) as indicated by phosphorylation of ERK (1/2).   
 In order to test if hunger is a physiological stimulus for AgRP/NPY neurons, we 
compared the effect of DHPG on AgRP/NPY neurons in fed and overnight fasted mice. We 
demonstrate that an overnight fast is sufficient to enhance mGluR1 mediated AgRP/NPY firing 
even beyond the high firing rate that occurs after fasting (Figure 3.3). This experiment shows 
that the ceiling for mGluR1 function is raised by overnight fasting. 
 Further , we demonstrated that mGluR1 signaling contributes to the increased firing of 
AgRP/NPY neurons that is typical of the fasted condition. Using current clamp 
electrophysiological recordings of AgRP/NPY neurons from fasted mice, we demonstrated that 
treatment with mGluR1 antagonist 3-MATIDA (Figure 3.4) reduces firing. This experiment 




 Next, we determined that group I metabotropic receptors function directly on AgRP/NPY 
neurons. After application and action of ionotropic synaptic blockade, we demonstrated a slow 
inward current on AgRP/NPY neurons by application of DHPG (Figure 3.5). This experiment 
clearly demonstrates direct action of group I metabotropic receptors on AgRP/NPY neurons on a 
subset of AgRP/NPY neurons.  
 Based on structural and functional evidence of mGluR1s on AgRP/NPY neurons, we 
tested the effect of mGluR1 antagonism on feeding behavior in overnight fasted mice. 
Unexpectedly, feeding behavior was unchanged within the first hour of refeeding, but was 
blunted at the 60-90 minute time point. This time point corresponds with time course data 
showing that ghrelin levels are cut in half within 60 minutes of refeeding52. Therefore, we 
surmise that as the pool of ghrelin-recruited AgRP/NPY neurons drops, the role of glutamatergic 
inputs becomes increasingly important – particularly by mGluR1. Despite limited effectiveness 
in reduction of feeding behavior over the first hour, the early onset of satiation by mGluR1 
antagonism indicates potential therapeutic value in modulating the tone of AgRP/NPY neurons 
via this receptors. Because ablating AgRP/NPY neurons in adult mice leads to starvation101, 186, a 
less drastic approach via modulation of the integration of glutamatergic inputs may be desirable. 
 Interface of conducted studies on exercise and hunger 
 The studies comprising this dissertation paint the ARC as a dynamic nuclei that integrates 
metabolic inputs with the capacity for potent output to regulate energy balance. This dissertation 
clearly demonstrates that nutritional status modulates the ARC on POMC and AgRP/NPY 
neurons. Further, this dissertation identifies two approaches towards reduced energy surplus by 




these conditions. The adaptations identified in this dissertation may be leveraged to develop 
future therapeutic approaches towards maintenance of energy balance for treatment of obesity 
and diabetes. While the ARC is only comprised of a few thousand cells comprising a very small 
percentage of the organism’s bodyweight, it has the capacity to control energy balance as 
coordinator of many organ systems.  
Limitations of Presented Experiments 
 For the study regarding the effect of exercise to prevent the damage of diet-induced 
obesity on the arcuate nucleus, we were unable to identify the precise mechanism of 
neuroprotection and reduced apoptosis. In addition, despite the fact that proliferation of new cells 
was limited, we were unable to determine the identity of these cells as neurons, astrocytes, or 
glial cells. In terms of leptin signaling, our experiment did not determine whether enhanced 
phosphorylation of STAT3 was caused by improved transport across the BBB, improved access 
to leptin receptor, or some change to intracellular signaling cascade that permitted enhancement 
of phosphorylation. A final limitation of this study is that it investigated concurrent improvement 
in the ARC and peripheral organs, therefore it inherently lacks of determination of a causal role 
by the arcuate nucleus to promote improvement across peripheral organs. 
 Our study regarding the effect of hunger on AgRP/NPY neuronal mGluR1 was limited 
from a number of angles. First, quantification of AgRP/NPY expression of mGluR1a/b by 
western blot is not specific to this neuronal subtype using microdissection, thus western blot of 
medial basal homogenate may reflect changes in other neurons populations. Using 
immunofluorescent reactivity, it is not clear if mGluR1 is expressed specifically on a cell within 




determination of the proportion of neurons that express a gene is single cell quantitative 
polymerase chain reaction (qPCR), but we steered clear of this approach because it doesn’t give 
any indication about the quantity of mRNA translated to mGluR1 or the amount present at a 
post-synaptic site. Further, if it is a post-translational modification that contributes to enhanced 
mGluR1 function by fasting the quantity of mGluR1 may be unchanged and largely irrelevant. 
Our in vitro investigation of mGluR1 was limited to measurement of ERK1/2 phosphorylation 
rather than direct measurement of activity IP3. In addition, the use of cutting edge mGluR1 
manipulators such as positive/negative allosteric modulators may prove beneficial for ex vivo 
recordings. The in vivo investigation of mGluR1 function is limited to antagonistic approaches 
due to epileptic seizures induced by agonism. An approach that knocks out GRM1 and 
conditionally re-expresses it within AgRP/NPY neurons may be required to fully verify that 
reduced feeding behavior caused by 3-MATIDA administration is via AgRP/NPY neurons.  
Towards the Future 
 Future studies should investigate the precise intracellular mechanisms involved in 
exercise induced neuroprotection of POMC neurons as this may yield specific targets for long 
term promotion of energy expenditure and satiety. On the other hand, studies should evaluate the 
effect of acute and chronic exercise on AgRP/NPY neurons to determine if energy expenditure 
promotes their activation in a manner consistent with hunger, and if these stimuli induce 













































































Figure 4.1 Adaptations of the arcuate nucleus of the hypothalamus in response to 
exercise and hunger.  Aim 1 includes experimentation to determine the effect of 
exercise to prevent high-fat diet induced POMC neuron apoptosis to support of energy 
expenditure. Aim 2 includes experimentation to determine the effect of hunger on 
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116. Morínigo R, Moizé V, Musri M, et al. Glucagon-Like Peptide-1, Peptide YY, 
Hunger, and Satiety after Gastric Bypass Surgery in Morbidly Obese Subjects. The 
Journal of Clinical Endocrinology & Metabolism. 2006;91:1735-1740. 
117. Moroni F, Attucci S, Cozzi A, et al. The novel and systemically active 
metabotropic glutamate 1 (mGlu1) receptor antagonist 3-MATIDA reduces post-ischemic 
neuronal death. Neuropharmacology. 2002;42:741-751. 
118. Mundell SJ, Pula G, Julia C. A. More, Jane DE, Roberts PJ, Kelly E. 
Activation of Cyclic AMP-Dependent Protein Kinase Inhibits the Desensitization and 
Internalization of Metabotropic Glutamate Receptors 1a and 1b. Molecular 
Pharmacology. 2004;65:1507-1516. 
119. Muroya S, Yada T, Shioda S, Takigawa M. Glucose-sensitive neurons in the rat 
arcuate nucleus contain neuropeptide Y. Neuroscience Letters. 1999;264:113-116. 
120. Myers MG, Olson DP. Central nervous system control of metabolism. Nature. 
2012;491:357-363. 
121. Myles TD, Gooch J, Santolaya J. Obesity as an independent risk factor for 
infectious morbidity in patients who undergo cesarean delivery. Obstetrics & 
Gynecology. 2002;100:959-964. 
122. Nakajima K, Cui Z, Li C, et al. Gs-coupled GPCR signalling in AgRP neurons 
triggers sustained increase in food intake. Nature Communications. 2016;7:10268. 
123. Naleid AM, Grace MK, Cummings DE, Levine AS. Ghrelin induces feeding in 
the mesolimbic reward pathway between the ventral tegmental area and the nucleus 
accumbens. Peptides. 2005;26:2274-2279. 
124. Navarro VM, Castellano JM, McConkey SM, et al. Interactions between 
kisspeptin and neurokinin B in the control of GnRH secretion in the female rat. American 
Journal of Physiology - Endocrinology And Metabolism. 2011;300:202-210. 
125. Naveau S, Giraud V, Borotto E, Aubert A, Capron F, Chaput J. Excess 
weight risk factor for alcoholic liver disease. Hepatology. 1997;25:108-111. 
126. Neeper SA, Gómez-Pinilla F, Choi J, Cotman CW. Physical activity increases 
mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain. Brain 
Research. 1996;726:49-56. 
127. Nestor CC, Qiu J, Padilla SL, et al. Optogenetic Stimulation of Arcuate Nucleus 
Kiss1 Neurons Reveals a Steroid-Dependent Glutamatergic Input to POMC and AgRP 




128. Nonomura T, Tsuchida A, Ono-Kishino M, Nakagawa T, Taiji M, Noguchi 
H. Brain-derived neurotrophic factor regulates energy expenditure through the central 
nervous system in obese diabetic mice. International Journal of Experimental Diabetes 
Research. 2001;2:201-209. 
129. Obici S, Feng Z, Karkanias G, Baskin DG, Rossetti L. Decreasing 
hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nature 
Neuroscience. 2002;5:566-572. 
130. Osmond RIW, Sheehan A, Borowicz R, et al. GPCR Screening via ERK 1/2: A 
Novel Platform for Screening G Protein–Coupled Receptors. Journal of Biomolecular 
Screening. Thousand Oaks, CA: Sage Publications; 2005;10:730-737. 
131. Paez X & Myers RD. Insatiable feeding evoked in rats by recurrent perfusion of 
neuropeptide Y in the hypothalamus. Peptides. 1991;12:609-616. 
132. Park M, Oh H, York DA. Enterostatin affects cyclic AMP and ERK signaling 
pathways to regulate Agouti-related Protein (AgRP) expression. Peptides. 2009;30:181-
190. 
133. Park S, Shim J, Kim J, et al. Insulin resistance is associated with hypertensive 
response to exercise in non-diabetic hypertensive patients. Diabetes Research and 
Clinical Practice. 2006;73:65-69. 
134. Patterson CM, Levin BE. Role of Exercise in the Central Regulation of Energy 
Homeostasis and in the Prevention of Obesity. Neuroendocrinology. 2007;2008;87:65-
70. 
135. Pérusse L, Collier G, Gagnon J, Rao DC, Skinner J, Wilmore J, et al.. Acute 
and chronic effects of exercise on leptin levels in humans. Journal of Applied Physiology. 
1997;83:5-10. 
136. Phillips CT, Palmiter RD. Role of Agouti-Related Protein-Expressing Neurons 
in Lactation. Endocrinology. 2008;149:544-550. 
137. Pocai A, Lam TKT, Obici S, et al. Restoration of hypothalamic lipid sensing 
normalizes energy and glucose homeostasis in overfed rats. The Journal of clinical 
investigation. 2006;116:1081-1091. 
138. Posey KA, Clegg DJ, Printz RL, et al. Hypothalamic proinflammatory lipid 
accumulation, inflammation, and insulin resistance in rats fed a high-fat diet. American 
Journal of Physiology - Endocrinology And Metabolism. 2009;296:1003-1012. 
139. Pouliot MC, Després JP, Nadeau A, et al. Visceral obesity in men. Associations 
with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes. 1992;41:826-
834. 
140. Powell CR, Tata S, Govani MV, Chien GW, Orvieto MA, Shalhav AL. 
Transplantation of a cadaveric polycystic kidney in a patient with autosomal dominant 





141. Qiu J, Nestor CC, Zhang C, et al. High-frequency stimulation-induced peptide 
release synchronizes arcuate kisspeptin neurons and excites GnRH neurons. eLife. 
2016;5. 
142. Rahmouni K, Correia MLG, Haynes WG, Mark AL. Obesity-Associated 
Hypertension: New Insights Into Mechanisms. Hypertension. 2005;2004;45:9-14. 
143. Riediger T, Bothe C, Becskei C, Lutz TA. Peptide YY Directly Inhibits 
Ghrelin-Activated Neurons of the Arcuate Nucleus and Reverses Fasting-Induced c-Fos 
Expression. Neuroendocrinology. 2004;79:317-326. 
144. Robertson RP. Oxidative stress and impaired insulin secretion in type 2 diabetes. 
Current Opinion in Pharmacology. 2006;6:615-619 
145. Rodríguez EM, Blázquez JL, Guerra M. The design of barriers in the 
hypothalamus allows the median eminence and the arcuate nucleus to enjoy private 
milieus: The former opens to the portal blood and the latter to the cerebrospinal fluid. 
Peptides. 2010;31:757-776. 
146. Ropelle ER, Flores MB, Cintra DE, et al. IL-6 and IL-10 Anti-Inflammatory 
Activity Links Exercise to Hypothalamic Insulin and Leptin Sensitivity through 
IKK[beta] and ER Stress Inhibition: e1000465. PLoS Biology. 2010;8. 
147. Sandoval D. CNS GLP-1 regulation of peripheral glucose homeostasis. 
Physiology & Behavior. 2008;94:670-674. 
148. Schaffhauser H, Cai Z, Hubalek F, Macek TA, Pohl J, Murphy T, Conn PJ. 
cAMP-Dependent Protein Kinase Inhibits mGluR2 Coupling to G-Proteins by Direct 
Receptor Phosphorylation. Journal of Neuroscience. 2000;20:5663-5670. 
149. Schwartz MW, Baskin DG, Hahn TM, Breininger JF. Coexpression of Agrp 
and NPY in fasting-activated hypothalamic neurons. Nature Neuroscience. 1998;1:271-
272. 
150. Schwartz MW, Marks JL, Sipols AJ, et al. Central insulin administration 
reduces neuropeptide Y mRNA expression in the arcuate nucleus of food-deprived lean 
(Fa/Fa) but not obese (fa/fa) Zucker rats. Endocrinology. 1991;128:2645-2647. 
151. Shiiya T, Nakazato M, Mizuta M, et al. Plasma ghrelin levels in lean and obese 
humans and the effect of glucose on ghrelin secretion. The Journal of clinical 
endocrinology and metabolism. 2002;87:240-244. 
152. Shimizu-Albergine M, Ippolito DL, Beavo JA. Downregulation of Fasting-
Induced cAMP Response Element-Mediated Gene Induction by Leptin in Neuropeptide 
Y Neurons of the Arcuate Nucleus. Journal of Neuroscience. 2001;21:1238-1246. 
153. Shin M, Shin M, Kim C, et al. Treadmill exercise suppresses diabetes-induced 
increment of neuropeptide Y expression in the hypothalamus of rats. Neuroscience 
Letters. 2003;346:157-160. 
154. Shiraishi T, Oomura Y, Sasaki K, Wayner MJ. Effects of leptin and orexin-A 





155. Shukla C, Koch LG, Britton SL, et al. Contribution of regional brain 
melanocortin receptor subtypes to elevated activity energy expenditure in lean, active 
rats. Neuroscience. 2015;310:252-267. 
156. Shulman GI. Cellular mechanisms of insulin resistance. The Journal of clinical 
investigation. 2000;106:171-176. 
157. Sinha MK, Opentanova I, Ohannesian JP, et al. Evidence of free and bound 
leptin in human circulation. Studies in lean and obese subjects and during short-term 
fasting. The Journal of clinical investigation. 1996;98:1277-1282. 
158. Skibicka KP, Hansson C, Alvarez-Crespo M, Friberg PA, Dickson SL. 
Ghrelin directly targets the ventral tegmental area to increase food motivation. 
Neuroscience. 2011;180:129-137. 
159. Small CJ, Liu YL, Stanley SA, et al. Chronic CNS administration of Agouti-
related protein (Agrp) reduces energy expenditure. International Journal of Obesity. 
2003;27:530-533. 
160. Smith MA, Mirshamsi S, Spanswick D, Routh VH, Ashford MLJ. Insulin 
activates ATP-sensitive K + channels in hypothalamic neurons of lean, but not obese rats. 
Nature Neuroscience. 2000;3:757-758. 
161. Smith SM, Vale WW. The role of the hypothalamic-pituitary-adrenal axis in 
neuroendocrine responses to stress. Dialogues in Clinical Neuroscience. 2006;8:383-395. 
162. Stengel B, Tarver-Carr ME, Powe NR, Eberhardt MS, Brancati FL. Lifestyle 
Factors, Obesity and the Risk of Chronic Kidney Disease. Epidemiology. 2003;14:479-
487. 
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